EVIO (EVIO) 10-Q 16 May 18 2018 Q2 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	6 Months Ended
	Mar. 31, 2018	May 16, 2018
Document And Entity Information
Entity Registrant Name	EVIO, INC.
Entity Central Index Key	715,788
Document Type	10-Q
Document Period End Date	Mar. 31, 2018
Amendment Flag	false
Current Fiscal Year End Date	--09-30
Is Entity a Well-known Seasoned Issuer?	No
Is Entity a Voluntary Filer?	No
Is Entity's Reporting Status Current?	Yes
Entity Filer Category	Smaller Reporting Company
Entity Common Stock, Shares Outstanding		17,266,903
Document Fiscal Period Focus	Q2
Document Fiscal Year Focus	2,018

CONSOLIDATED BALANCE SHEETS

CONSOLIDATED BALANCE SHEETS - USD ($)	Mar. 31, 2018	Sep. 30, 2017
Current assets:
Cash	$ 3,021,247	$ 121,013
Accounts receivable, net of allowance of $77,850 and $74,782	215,540	229,564
Prepaid expenses	91,603	169,557
Other current asset	63,546	7,438
Note receivable, current portion	100,000	100,000
Total current assets	3,491,936	627,572
Property and equipment, net of accumulated depreciation of $345,308 and $213,447, respectively	1,616,796	547,073
Security deposits	564,215	92,892
Note receivable, net of current portion	1,239,987	1,200,000
Deposit, related party	200,000
Intangible assets, net of accumulated amortization, net of accumulated amortization of $283,589 and $189,475	945,146	592,260
Goodwill	3,249,834	2,958,137
Total assets	11,307,914	6,017,934
Current liabilities
Accounts payable and accrued liabilities	698,672	773,053
Client deposits	49,696	119,281
Deferred revenue	27,000	40,800
Interest payable	296,886	133,697
Capital lease obligation, current	140,184	37,990
Derivative liability	3,123,223	294,637
Convertible notes payable, net of discounts of $499,998 and $208,680, respectively	718,187	1,212,720
Loans payable, current, net of discounts of $37,024 and $127,662	975,192	1,503,545
Loans payable, related party, current	153,155	312,855
Total current liabilities	6,182,195	4,428,578
Convertible debentures payable, net of discounts of $6,229,111 and $0, respectively	353,889
Capital lease obligation, net of current portion	313,444	52,777
Loans payable, net of current portion	53,475	59,832
Loans payable, related party, net of current portion, net of discounts of $32,066 and $42,044, respectively	1,190,428	1,251,306
Total liabilities	8,093,431	5,792,493
Stockholders equity
Common Stock, Par Value $.0001, 1,000,000,000 authorized; 16,068,505 and 10,732,922 issued and outstanding at March 31, 2018 and September 30, 2017, respectively	1,607	1,073
Additional Paid In Capital	12,925,708	7,657,982
Accumulated Deficit	(10,258,765)	(7,592,371)
Total stockholders'equity	2,669,155	67,317
Non-controlling interest	545,328	158,124
Total equity	3,214,483	225,441
Total liabilities and stockholders' equity	11,307,914	6,017,934
Series A Preferred Stock [Member]
Stockholders equity
Convertible Preferred Stock
Series B Preferred Stock [Member]
Stockholders equity
Convertible Preferred Stock	500	500
Series C Preferred Stock [Member]
Stockholders equity
Convertible Preferred Stock	50	50
Series D Preferred Stock [Member]
Stockholders equity
Convertible Preferred Stock	$ 55	$ 83

CONSOLIDATED BALANCE SHEETS (Pa

CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($)	Mar. 31, 2018	Sep. 30, 2017
Current assets:
Accounts receivable, net of allowance	$ 77,850	$ 74,782
Property and equipment, net of accumulated depreciation	345,308	213,447
Intangible assets, net of accumulated amortization	283,589	189,475
Current liabilities
Convertible notes payable, net of discounts	499,998	208,680
Loans payable, current, net of discounts	37,024	127,662
Noncurrent liabilities
Convertible debentures payable, net of discounts	6,229,111	0
Loans payable, related party	$ 32,066	$ 42,044
Stockholders' equity
Common stock, par value	$ 0.0001	$ 0.0001
Common stock, shares authorized	1,000,000,000	1,000,000,000
Common stock, shares issued	16,068,505	10,732,922
Common stock, shares outstanding	16,068,505	10,732,922
Series A Preferred Stock [Member]
Stockholders' equity
Convertible Preferred Stock, Par Value	$ 0.0001	$ 0.0001
Convertible Preferred Stock, Shares Authorized	1,850,000	1,850,000
Convertible Preferred Stock, Shares Issued	0	0
Convertible Preferred Stock, Shares Outstanding	0	0
Common stock, shares issued	500,000,000
Common stock, shares outstanding	500,000,000
Series B Preferred Stock [Member]
Stockholders' equity
Convertible Preferred Stock, Par Value	$ 0.0001	$ 0.0001
Convertible Preferred Stock, Shares Authorized	5,000,000	5,000,000
Convertible Preferred Stock, Shares Issued	5,000,000	5,000,000
Convertible Preferred Stock, Shares Outstanding	5,000,000	5,000,000
Series C Preferred Stock [Member]
Stockholders' equity
Convertible Preferred Stock, Par Value	$ 0.0001	$ 0.0001
Convertible Preferred Stock, Shares Authorized	500,000	500,000
Convertible Preferred Stock, Shares Issued	500,000	500,000
Convertible Preferred Stock, Shares Outstanding	500,000	500,000
Series D Preferred Stock [Member]
Stockholders' equity
Convertible Preferred Stock, Par Value	$ 0.0001	$ 0.0001
Convertible Preferred Stock, Shares Authorized	1,000,000	1,000,000
Convertible Preferred Stock, Shares Issued	552,500	832,500
Convertible Preferred Stock, Shares Outstanding	552,500	832,500

UNAUDITED CONSOLIDATED STATEMEN

UNAUDITED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)	3 Months Ended		6 Months Ended
	Mar. 31, 2018	Mar. 31, 2017	Mar. 31, 2018	Mar. 31, 2017
Revenues
Testing services	$ 689,011	$ 745,426	$ 1,576,360	$ 1,314,004
Consulting services	43,300	87,297	102,816	187,175
Total revenue	732,311	832,723	1,679,176	1,501,179
Cost of revenues
Testing services	664,182	566,447	1,360,840	1,125,724
Consulting services	78,500	19,505	88,992	32,005
Depreciation and amortization	55,706	28,048	84,819	46,350
Total cost of revenues	798,388	614,000	1,534,651	1,204,079
Gross margin	(66,077)	218,723	144,525	297,100
Operating expenses
Selling, general and administrative	2,213,094	460,736	3,033,369	895,894
Depreciation and amortization	83,769	39,845	141,156	74,380
Total operating expenses	2,296,863	500,581	3,174,525	970,274
Loss from operations	(2,362,940)	(281,858)	(3,030,000)	(673,174)
Other income (expense)
Interest expense, net of interest income	(1,102,537)	(97,987)	(1,387,188)	(421,409)
Loss on settlement of debt and account payable			(56,093)
Gain (loss) on change in fair market value of derivative liabilities	1,780,769	(85,035)	1,794,091	(191,278)
Total other income (expense)	678,232	(183,022)	350,810	(612,687)
Net Loss	(1,684,708)	(464,880)	(2,679,190)	(1,285,861)
Gain (loss) attributable to non-controlling interest	(4,906)	4,554	(12,796)	9,290
Net loss attributable to EVIO, Inc.	$ (1,679,802)	$ (469,434)	$ (2,666,394)	$ (1,295,151)
Basic and diluted loss per common share	$ (0.11)	$ (0.05)	$ (0.20)	$ (0.14)
Weighted average common shares outstanding	15,387,039	9,490,789	13,519,957	9,154,929

UNAUDITED CONSOLIDATED STATEME5

UNAUDITED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)	6 Months Ended
	Mar. 31, 2018	Mar. 31, 2017
Cash flows from operating activities
Net loss	$ (2,679,190)	$ (1,285,861)
Adjustments to reconcile net loss to net cash used in operating activities:
Stock based compensation	1,234,415	247,951
Common stock issued for services	254,720
Loss on settlement of debt	52,343
Loss on settlement of account payable	3,750
(Gain) loss on derivative liability	(1,794,091)	191,278
Amortization of debt discount	1,199,159	357,552
Depreciation and amortization expense	225,975	120,730
Allowance for doubtful accounts	3,067
Reduction of security deposit for rent expense		2,095
Changes in operating assets and liabilities:
Accounts receivable	16,067	(196,738)
Prepaid expenses	77,954	(973)
Other current asset	(52,647)	40,000
Security deposit	(451,323)	(6,418)
Accounts payable and accrued liabilities	(348,073)	274,601
Interest payable	192,616	56,826
Deferred revenue	(13,800)
Customer deposits	(69,585)	136,645
Net cash used in operating activities	(2,148,643)	(62,312)
Cash flows from investing activities
Net cash acquired (paid) in acquisitions of subsidiaries	20,468	(6,930)
Note receivable	(39,987)
Deposit, related party	(200,000)
Purchase of equipment	(571,501)	(45,764)
Net cash used in investing activities	(791,020)	(52,694)
Cash flows from financing activities
Repayments of capital leases	(22,347)	(4,590)
Proceeds from issuance of convertible debenture	6,136,120
Proceeds from issuance of common stock	508,000	20,000
Proceeds from the issuance of series D preferred stock		114,500
Proceeds from convertible notes, net of original issue discounts and fees		390,000
Payment on loan payable	(605,348)	(54,875)
Proceeds from notes payable - related party		80,100
Payments on notes payable - related party	(176,528)	(223,022)
Net cash provided by financing activities	5,839,897	322,113
Net cash increase for period	2,900,234	207,107
Cash balance, beginning of period	121,013	57,486
Cash balance, end of period	3,021,247	264,593
Supplemental disclosure of cash flow information:
Cash paid for interest	80,028	7,034
Cash paid for income tax
Supplemental disclosure of non-cash investing and financing activities
Conversion of convertible note and accrued interest into common stock	730,485	316,457
Reclassification of derivative liability to additional paid in capital	882,454	889,509
Settlement of account payable for common stock	18,750
Common stock issued for settlement of note payable	162,000
Common stock issued for settlement of related party note payable	62,500
Conversion of Series D Preferred stock to common stock	70
Debt discount recorded on convertible notes and convertible debentures payable upon initial measurement of derivative liability	5,505,131	351,600
Debt discounts recorded for original issue discounts on convertible notes and convertible debentures payable	446,800	13,300
Vehicles financed through notes payable		75,165
Equipment financed through capital leases	385,208	105,120
Debt discount from derivative liability		351,600
Conversion of Series A Preferred stock to common stock		4,388
Acquisition of C3 Labs through the issuance of note payable and convertible note payable	600,000
Acquisition of GreenStyle Consulting assets through issuance of preferred shares, cash and note payable		260,000
Acquisition of GreenHaus through issuance of preferred shares and note payable		$ 800,000

NATURE OF ACTIVITIES AND CONTIN

NATURE OF ACTIVITIES AND CONTINUANCE OF BUSINESS	6 Months Ended
	Mar. 31, 2018
Notes to Financial Statements
NOTE 1 - NATURE OF ACTIVITIES AND CONTINUANCE OF BUSINESS	EVIO, Inc., a Colorado corporation and its subsidiaries (“the Company”) provide analytical testing and advisory services to the emerging legalized cannabis industry. On August 29, 2014, Signal Bay Research completed a reverse merger with a shell company, Quantech Electronics, and in September 2014, changed its name and assumed its operations as Signal Bay. As a part of and prior to the consummation of the reverse merger, William Waldrop and Lori Glauser, principals of Signal Bay Research, Inc., purchased 80% of the issued and outstanding common stock from WB Partners. The merger between the Company and Signal Bay Research was finalized and closed contemporaneously with the share purchase. As part of this share purchase, Mr. Waldrop and Ms. Glauser became the officers and directors of the Company. In September 2014, the Company changed its name to Signal Bay, Inc. and then to EVIO, INC. in September 2017. EVIO, Inc. has selected September 30 as its fiscal year end. The Company is domiciled in the State of Colorado, and its corporate headquarters are located in Bend, Oregon. Signal Bay Services was formed on January 25, 2015, as the management services division of EVIO. On September 17, 2015, the Company entered into a share exchange agreement with CR Labs, Inc., an Oregon Corporation, pursuant to which the Company acquired 80% of the outstanding common stock of CR Labs, Inc. EVIO Labs OR Inc. was formed on April 4, 2016 to become the holding company for all laboratory operations in Oregon. EVIO Labs Eugene, LLC was formed on May 23, 2016, as a wholly owned subsidiary of EVIO Inc. Subsequently on May 24, 2016, EVIO Labs Eugene acquired all of the assets of Oregon Analytical Services, LLC, inclusive of client lists, equipment, trade names and personnel. On June 1, 2016, the Company entered into a share purchase agreement to purchase 80% of the outstanding common stock of Smith Scientific Industries, Inc. d/b/a Kenevir Research in Medford, OR. On October 19, 2016, the Company entered into a Membership Interest Purchase Agreement to purchase 100% of the ownership of GreenHaus Analytical Labs, LLC (“GreenHaus”). GreenHaus is a full-service cannabis testing laboratory. On October 26, 2016, the Company entered in to an Asset Purchase Agreement with Green Style Consulting, LLC which was closed on November 1, 2016 (“GreenStyle”). GreenStyle is a full-service cannabis testing laboratory. The Company entered in to a Membership Interest Purchase Agreement with Viridis Analytics MA, LLC (“Viridis”) which was closed on August 1, 2017. Viridis is a full-service cannabis testing laboratory. On December 29, 2017, the Company entered in to an Membership Purchase Agreement to purchase 60% of the outstanding interests of C3 Labs, LC, LLC which was closed on January 1, 2018 (“C3”). C3 is a full-service cannabis testing laboratory. See Note 10 – Acquisitions. Going Concern The Company's financial statements are prepared using accounting principles generally accepted in the United States of America applicable to a going concern, which contemplates the realization of assets and liquidation of liabilities in the normal course of business. However, the Company has negative working capital, recurring losses, and does not have an established source of revenues sufficient to cover its operating costs. These factors raise substantial doubt about the Company’s ability to continue as a going concern. The ability of the Company to continue as a going concern is dependent upon its ability to successfully accomplish the plan described in the preceding paragraph and eventually attain profitable operations. The accompanying financial statements do not include any adjustments that may be necessary if the Company is unable to continue as a going concern. In the coming year, the Company’s foreseeable cash requirements will relate to continual development of the operations of its business, maintaining its good standing and making the requisite filings with the Securities and Exchange Commission, and the payment of expenses associated with operations and business developments. The Company may experience a cash shortfall and be required to raise additional capital. Historically, it has mostly relied upon internally generated funds such as shareholder loans and advances to finance its operations and growth. Management may raise additional capital by retaining net earnings or through future public or private offerings of the Company’s stock or through loans from private investors, although there can be no assurance that it will be able to obtain such financing. The Company’s failure to do so could have a material and adverse effect upon it and its shareholders.

SUMMARY OF SIGNIFICANT ACCOUNTI

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	6 Months Ended
	Mar. 31, 2018
Notes to Financial Statements
NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	Basis of Presentation The accompanying unaudited interim consolidated financial statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States of America and the rules of the Securities and Exchange Commission, and should be read in conjunction with the audited consolidated financial statements and notes thereto contained in the Company’s most recent Annual Financial Statements filed with the SEC on Form 10-K. In the opinion of management, all adjustments, consisting of normal recurring adjustments, necessary for a fair presentation of financial position and the results of operations for the interim period presented have been reflected herein. The results of operations for the interim period are not necessarily indicative of the results to be expected for the full year. Notes to the financial statements which would substantially duplicate the disclosures contained in the audited consolidated financial statements for the most recent fiscal period, as reported in the Form 10-K, have been omitted. Principles of Consolidation The Company prepares its financial statements on the accrual basis of accounting. The accompanying consolidated financial statements include the accounts of the Company and its wholly and partially owned subsidiaries, all of which have a fiscal year end of September 30. All intercompany accounts, balances and transactions have been eliminated in the consolidation. The Company consolidates its subsidiaries in accordance with ASC 810, and specifically ASC 810-10-15-8 which states, the usual condition for a controlling financial interest is ownership of a majority voting interest, and, therefore, as a general rule ownership by one reporting entity, directly or indirectly, or over 50% of the outstanding voting shares of another entity is a condition pointing toward consolidation. Use of Estimates The preparation of financial statements in accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. A change in managements’ estimates or assumptions could have a material impact on the Company’s financial condition and results of operations during the period in which such changes occurred. Actual results could differ from those estimates. The Company’s financial statements reflect all adjustments that management believes are necessary for the fair presentation of their financial condition and results of operations for the periods presented. Financial Instruments Level 1 - applies to assets or liabilities for which there are quoted prices in active markets for identical assets or liabilities. Level 2 - applies to assets or liabilities for which there are inputs other than quoted prices that are observable for the asset or liability such as quoted prices for similar assets or liabilities in active markets; quoted prices for identical assets or liabilities in markets with insufficient volume or infrequent transactions (less active markets); or model-derived valuations in which significant inputs are observable or can be derived principally from, or corroborated by, observable market data. Level 3 - applies to assets or liabilities for which there are unobservable inputs to the valuation methodology that are significant to the measurement of the fair value of the assets or liabilities. The Company's financial instruments consist principally of cash, accounts payable, and accrued liabilities. Pursuant to ASC 820 and 825, the fair value of cash is determined based on "Level 1" inputs, which consist of quoted prices in active markets for identical assets. The recorded values of all other financial instruments approximate their current fair values because of their nature and respective maturity dates or durations. The following table sets forth by level with the fair value hierarchy the Company's financial assets and liabilities measured at fair value on March 31, 2018: Level 1 Level 2 Level 3 Total Liabilities Derivative financial instruments $ - $ - $ 3,123,223 $ 3,123,223 The following table sets forth by level with the fair value hierarchy the Company's financial assets and liabilities measured at fair value on September 30, 2017: Level 1 Level 2 Level 3 Total Liabilities Derivative financial instruments $ - $ - $ 294,637 $ 294,637 Recently Issued Accounting Pronouncements In January 2017, the FASB issued ASU 2017-04, “ Intangibles—Goodwill and Other (Topic 350), Simplifying the Test for Goodwill Impairment”. In January 2017, the FASB issued ASU 2017-01, “ Business Combinations (Topic 805): Clarifying the Definition of a Business, In April 2016, the FASB issued ASU 2016-10, "Revenue from Contracts with Customers (Topic 606): Identifying Performance Obligations and Licensing" ("ASU 2016-1O"). The amendments in this update clarify the following two aspects to Topic 606: identifying performance obligations and the licensing implementation guidance, while retaining the related principles for those areas. The entity first identifies the promised goods or services in the contract and reduces the cost and complexity. An entity evaluates whether promised goods and services are distinct. Topic 606 includes implementation guidance on determining whether an entity's promise to grant a license provides a customer with either a right to use the entity's intellectual property (which is satisfied at a point in time) or a right to access the entity's intellectual property (which is satisfied over time). The Company evaluated the impacts of ASU 2016-10 and does not believe it will an impact on the Company’s revenue recognition practices and will adopt the standard on October 1, 2018. Other accounting standards that have been issued or proposed by the FASB or other standards-setting bodies that do not require adoption until a future date are not expected to have a material impact on our financial statements upon adoption Net Income (Loss) Per Share Basic loss per share is computed by dividing net income, or loss, by the weighted average number of shares of common stock outstanding for the period. Diluted earnings (loss) per share is computed by dividing net income, or loss, by the weighted average number of shares of common stock outstanding for the period. There were 13,688,531 and 9,958,808 potentially dilutive common shares outstanding as of March 31, 2018 and 2017. Because of the net losses incurred during the three and six months ended March 31, 2018 and 2017, the impacts of dilutive instruments would have been anti-dilutive for the period presented and have been excluded from the diluted loss per share calculations. Accounts Receivable and Allowance for Doubtful Accounts Accounts receivable are recorded at their original invoice amounts. We regularly review collectability and establish an allowance for uncollectible amounts as necessary based on our experience with historical collectability. There was an allowance for uncollectible accounts receivable of $77,850 and $74,782 as of March 31, 2018 and September 30, 2017, respectively. Notes Receivable The Company accounts investments for notes receivable in accordance with ASC 320. On September 6, 2017, the Company entered in a note receivable with an unrelated entity for $1,300,000. During the six months ended March 31, 2018, the Company made additional advances of $39,987. The note is due on September 6, 2024 and carries interest at a rate of 8% per annum. The note requires minimum principal payments of $100,000 plus accrued interest on each anniversary date with the unpaid principal and interest being due on September 6, 2024. The Company evaluated the collectability of the note receivable as of March 31, 2018 and September 30, 2017 and determined the full balance is collectible and no reserve for write off was recorded. As of March 31, 2018 and September 30, 2017, there was $1,339,987 of principal, of which $100,000 was current and $1,239,987 was long term. Additionally, there was $59,485 and $6,838 of interest due as of March 31, 2018 and September 30, 2017 which is included in other current assets. Goodwill and Other Intangible Assets Goodwill and indefinite-lived intangible assets are not amortized but are evaluated for impairment annually or more often if indicators of a potential impairment are present. Our annual impairment tests are conducted at the beginning of the fourth quarter. We use a two-step process to quantitatively evaluate goodwill for impairment. In the first step, we compare the fair value of each reporting unit with the carrying amount of the reporting unit, including goodwill. If the estimated fair value of the reporting unit is less than the carrying amount of the reporting unit, we complete a second step to determine the amount of the goodwill impairment that we should record. In the second step, we determine an implied fair value of the reporting unit's goodwill by allocating the reporting unit's fair value to all of its assets and liabilities other than goodwill (including any unrecognized intangible assets). We compare the resulting implied fair value of the goodwill to the carrying amount and record an impairment charge for the difference. We test individual indefinite-lived intangible assets by comparing the estimated fair value with the book values of each asset. The Company recognizes an acquired intangible apart from goodwill whenever the intangible arises from contractual or other legal rights, or whenever it can be separated or divided from the acquired entity and sold, transferred, licensed, rented or exchanged, either individually or in combination with a related contract, asset or liability. Such intangibles are amortized on a straight-line basis over their estimated useful lives unless the estimated useful life is determined to be indefinite. The Company’s intangible assets consist of client lists (amortized over five years), websites, non-compete agreements (amortized over 5 years), domain names (amortized over 15 years) and testing licenses (amortized over 5 years). Stock-Based Compensation The Company applies Topic 718 “Share-Based Payments” (“Topic 718”) to share-based compensation, which requires the measurement of the cost of services received in exchange for an award of an equity instrument based on the grant-date fair value of the award. Compensation cost is recognized when the event occurs. The Black-Scholes option-pricing model is used to estimate the fair value of options granted. The Company accounts for equity-based transactions with non-employees under the provisions of ASC Topic No. 505-50, “Equity-Based Payments to Non-Employees” (“Topic No. 505-50”). Topic No. 505-50 establishes that equity-based payment transactions with non-employees shall be measured at the fair value of the consideration received or the fair value of the equity instruments issued, whichever is more reliably measurable. Non-Controlling Interest The Company reports the non-controlling interest in its majority owned subsidiaries in the consolidated balance sheets within the stockholders’ deficit section, separately from the Company’s stockholders’ deficit. Non-controlling interest represents the non-controlling interest holders’ proportionate share of the equity of the Company’s majority-owned subsidiaries. Non-controlling interest is adjusted for the non-controlling interest holders’ proportionate share of the earnings or losses and other comprehensive income (loss) and the non-controlling interest continues to be attributed its share of losses even if that attribution results in a deficit non-controlling interest balance. Related Parties The registrant follows subtopic 850-10 of the FASB Accounting Standards Codification for the identification of related parties and disclosure of related party transactions. Pursuant to Section 850-10-20 the Related parties include (a) affiliates of the registrant; (b) entities for which investments in their equity securities would be required, absent the election of the fair value option under the Fair Value Option Subsection of Section 825–10–15, to be accounted for by the equity method by the investing entity; (c) trusts for the benefit of employees, such as pension and profit-sharing trusts that are managed by or under the trusteeship of management; (d) principal owners of the registrant; (e) management of the registrant; (f) other parties with which the registrant may deal if one party controls or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests; and (g) Other parties that can significantly influence the management or operating policies of the transacting parties or that have an ownership interest in one of the transacting parties and can significantly influence the other to an extent that one or more of the transacting parties might be prevented from fully pursuing its own separate interests. The financial statements shall include disclosures of material related party transactions, other than compensation arrangements, expense allowances, and other similar items in the ordinary course of business. However, disclosure of transactions that are eliminated in the preparation of consolidated or combined financial statements is not required in those statements. The disclosures shall include: (a) the nature of the relationship(s) involved; (b) description of the transactions, including transactions to which no amounts or nominal amounts were ascribed, for each of the periods for which income statements are presented, and such other information deemed necessary to an understanding of the effects of the transactions on the financial statements; (c) the dollar amounts of transactions for each of the periods for which income statements are presented and the effects of any change in the method of establishing the terms from that used in the preceding period; and (d) amounts due from or to related parties as of the date of each balance sheet presented and, if not otherwise apparent, the terms and manner of settlement. Capital Leases The Company accounts for capital leases in accordance with ACS 840-30. During the year ended September 30, 2017, the Company entered into three separate long-term leases for equipment that contain a $1 buyout option upon lease termination. The Company determined these were capital leases based on the minimum buy out price and capitalized the net present value of the leases which totaled $116,800 as equipment. On February 2, 2018, the Company entered into a long term lease for equipment that contain a bargain purchase option upon lease termination. The Company determined this was a capital lease based on the minimum buy out price and capitalized the net present value of the lease of $385,208 plus the required up front cash payment of $39,986 which totaled $425,194 as equipment. As of September 30, 2017, there was a total of $111,501 of future payments due through December 2019 of which $20,734 are financing charges leaving a total principal balance of $90,967 as of September 30, 2017. Of this amount, $37,990 was current and $52,777 was long term as of September 30, 2017. As of March 31, 2018, there was a total of $499,242 of future payments due through March 2021 of which $45,614 are financing charges leaving a total principal balance of $453,628 as of March 31, 2018. Of this amount, $140,184 was current and $313,444 was long term as of March 31, 2018. Future annual payments required under the capital leases through termination are as follows: Year ended September 30, Principal Interest Total 2018 $ 69,198 $ 14,390 $ 83,588 2019 144,889 19,671 164,560 2020 121,904 9,210 131,114 2021 117,637 2,343 119,980 Total $ 453,628 $ 45,614 $ 499,242 Concentration of Credit Risk Instruments that potentially subject the Company to concentration of credit risk consist principally of cash deposits, notes receivable and accounts receivable. As of March 31, 2018 and September 30, 2017, the Company held $2,472,536 and $0 of cash at one financial institution in excess of the amount insured by the Federal Deposit Insurance Corporation (“FDIC”) of up to $250,000. As of March 31, 2018 and September 30, 2017, the Company had a note receivable totaling $1,339,987 and $1,300,000 due from a single entity. As of September 30, 2017, the Company had total accounts receivable net of allowances of $229,564. Three separate clients comprised a total of 41% of this balance as follows: Balance Percent of Total Customer 1 $ 42,878 14 % Customer 2 45,635 15 % Customer 3 37,540 12 % All others 178,294 59 % Total 304,347 100 % Allowance for doubtful accounts (74,783 ) Net accounts receivable $ 229,564 As of March 31, 2018 the Company had total accounts receivable net of allowances of $215,540. Three separate clients comprised a total of 35% of this balance as follows: Balance Percent of Total Customer 1 $ 33,219 11 % Customer 2 45,635 16 % Customer 3 36,600 12 % All others 177,936 61 % Total 293,390 Allowance for doubtful accounts (77,850 ) Net accounts receivable $ 215,540 Property and Equipment Property and equipment are carried at cost. Expenditures for maintenance and repairs are expensed in the period incurred. Renewals and betterments that materially extend the life of the assets are capitalized. When assets are retired or otherwise disposed of, the cost and related accumulated depreciation are removed from the accounts, and any resulting gain or loss is reflected in income for the period. Depreciation is computed for financial statement purposes on a straight-line basis over estimated useful lives of the related assets and the modified accelerated cost recovery system for federal income tax purposes. The estimated useful lives of depreciable assets are: Estimated Useful Lives Laboratory and Computer Equipment 5 years Furniture and Fixtures 7 years Software 3 years Domains 15 years The Company’s property and equipment consisted of the following as of March 31, 2018 and September 30, 2017: March 31, 2018 September 30, 2017 Furniture and Equipment $ 169,051 $ 146,870 Laboratory Equipment 1,543,487 439,071 Software 58,333 58,333 Leasehold Improvements 107,318 41,081 Vehicles 83,915 75,165 Total 1,962,104 760,520 Accumulated depreciation (345,308 ) (213,447 ) Net value $ 1,616,796 $ 547,073 The Company capitalized a total of $425,194 of equipment purchased through capital leases and recorded depreciation expense of $23,619 and $6,029 and $33,064 and $8,134 and on that equipment during the three and six months ended March 31, 2018 and 2017, respectively.

INTANGIBLE ASSETS

INTANGIBLE ASSETS	6 Months Ended
	Mar. 31, 2018
Notes to Financial Statements
NOTE 3 - INTANGIBLE ASSETS	The Company’s intangible assets consist of customer lists, testing licenses, favorable leases and websites. The components of intangible assets as of March 31, 2018 and September 30, 2017 consist of: March 31, 2018 September 30, 2017 Customer list $ 592,670 $ 480,670 License 503,000 256,000 Favorable lease 3,100 3,100 Website 41,965 41,965 Non-compete agreement 88,000 - Total 1,228,735 781,735 Accumulated amortization (283,589 ) (189,475 ) Net value $ 945,146 $ 592,260 The Company estimates amortization to be recorded on existing intangible assets through the estimated lives to be: For the years ended September 30, Amortization 2018 $ 109,268 2019 218,537 2020 218,537 2021 176,362 2022 78,607 Thereafter 143,835 Total $ 945,146

RELATED PARTY TRANSACTIONS

RELATED PARTY TRANSACTIONS	6 Months Ended
	Mar. 31, 2018
Notes to Financial Statements
NOTE 4 - RELATED PARTY TRANSACTIONS	Through September 30, 2017, the Company received loans from its Chief Operating Officer totaling $106,000 and made repayments totaling $21,795 leaving a balance due as of September 30, 2017 of $84,205. Additionally, the Company made repayments totaling $60,000 during the six months ended March 31, 2018. The advances are non-interest bearing and due on demand. There was $24,204 and $84,205 due as of March 31, 2018 and September 30, 2017, and is included in the accompanying consolidated balance sheets as a current portion of notes payable to related parties. During the three and six months ended March 31, 2018 and 2017, the Company incurred total expenses of $2,000 and $13,124 and $14,317 and $27,672, respectively, for management consulting services performed by Newport Commercial Advisors, an entity fully owned and controlled by our Chief Executive Officer. There was not a balance payable to Newport Commercial Advisors as of March 31, 2018 or September 30, 2017. During the year ended September 30, 2017, the Company received loans from its Chief Executive Officer totaling $80,100 and made repayments totaling $75,650. There were no additional advances or repayments made during the six months ended March 31, 2018. The loans are non-interest bearing and due on demand. There was $4,450 due as of March 31, 2018 and September 30, 2017. During the year ended September 30, 2017 the Company made repayments to Eric Ezrine, a shareholder of CR Labs, on an outstanding note payable totaling $13,139. The loans carry an interest rate of 0% per annum. There was $130 due as of March 31, 2018 and September 30, 2017. Additionally, the Company entered into a severance agreement with Mr. Ezrine whereby it agreed to make payments totaling $44,500 through August 2018. The Company made repayments of $22,050 during the year ended September 30, 2017 and $14,000 during the six months ended March 31, 2018. There was $8,450 and $22,450 accrued as of March 31, 2018 and September 30, 2017, respectively. On May 24, 2016, the Company executed an asset purchase agreement with Sara Lausmann, managing member owner of Oregon Analytical Services, LLC, for $972,500. The terms of the purchase required the issuance of 200,000 shares of Series C Preferred Stock, valued at $80,000, $72,500 in a short-term loan and $700,000 in a long-term note. Through the year ended September 30, 2017, the Company repaid a total of $82,630 to Sara Lausmann, Vice President Client Services. The Company made additional repayments of $59,000 during the six months ended March 31, 2018. The total amount outstanding is $630,870 and $689,870 as of March 31, 2018 and September 30, 2017, respectively. As of March 31, 2018 and September 30, 2017, $74,370 and $89,870 and $556,500 and $600,000 are included in the accompanying consolidated balance sheets as current and long-term portions of notes payable to related party, respectively. The notes carry interest at a rate of 5% per annum and had accrued interest totaling $64,222 and $47,409 due as of March 31, 2018 and September 30, 2017, respectively. On June 1, 2016, the Company executed a share purchase agreement with Anthony Smith, for the purchase of 80% of Smith Scientific Industries for $636,000. The terms of the purchase required the issuance of 300,000 shares of Series C Preferred Stock, valued at $135,000 and $336,000 in a promissory note. During the year ended September 30, 2017, the Company repaid $50,000 to Anthony Smith, our Chief Science Officer. During the six months ended March 31, 2018, the Company made repayments totaling $25,000. The note carries interest at a rate of 5% per annum. There was $236,000 and $261,000 of principal due as of March 31, 2018 and September 30, 2017 and $25,044 and $18,846 of accrued interest due as of March 31, 2018 and September 30, 2017, respectively. On October 19, 2016, the Company assumed a $194,512 payable due to Henry Grimmett, and officer of Greenhaus and current Director of the Company, with its acquisition of Greenhaus Analytical Services, LLC. The note bears interest at 0% per annum and requires repayments of $25,000 quarterly. During the year ended September 30, 2017, the Company made repayments totaling $25,100. Additionally, during the six months ended March 31, 2018, the Company made cash repayments of $2,000 and agreed to issue 125,000 shares of common stock valued at $62,500 for the settlement of $50,000 of principal resulting in a loss on the settlement of debt of $15,000. There was a total of $117,412 and $169,412 due as of March 31, 2018 and September 30, 2017 of which $50,000 is current and $67,412 is long term. On October 19, 2016, the Company entered into a $340,000 note payable as part of its acquisition of Greenhaus Analytical Services, LLC. At the time of issuance, the note carried a debt discount of $55,277. The note carries interest at a rate of 6% per annum and matures on October 16, 2020. There was $340,000 of principal, an unamortized debt discount of $35,158 and $42,044 and $29,678 and $19,506 of accrued interest due as of March 31, 2018 and September 30, 2017, respectively. On November 1, 2016, the Company entered into a $50,000 note payable, that contained a premium of $7,416 based on fair value, to Green Style Consulting, LLC. The Green Style Consulting, LLC Managing Member is our General Manager Northern California, who was hired by the Company concurrent to the asset purchase. The note carries interest at a rate of 5% per annum and matures on October 31, 2018. During the year ended September 30, 2017 and the six months ended March 31, 2018, the Company made repayments of $6,090 and $21,328. There was $22,582 and $43,910 of principal, $3,093 and $4,028 of unamortized note premium and $436 and $2,055 of accrued interest due as of March 31, 2018 and September 30, 2017, respectively. On October 19, 2016, the Company entered into an asset purchase agreement with Green Style Consulting LLC requiring a future share of net profits generated by Green Style Consulting. The fair value of these future net profits were estimated to be $15,809. There have been no monthly net profits to distribute from the time of acquisition to March 31, 2018 and as such no repayments have been made. There was $15,809 accrued and included in accounts payable and accrued liabilities for future payments related to this earn out as of March 31, 2018 and September 30, 2017. Through September 30, 2016, the Company borrowed a total of $16,200 from our Chief Science Officer to fund operations. The loans are non-interest bearing, due on demand and as such are included in current liabilities. During the year ended September 30, 2017 and the six months ended March 31, 2018, the Company made repayments totaling $7,000 and $9,200, respectively. There was $0 and $9,200 due as of March 31, 2018 and September 30, 2017, respectively. On March 5, 2018, the Company entered into an agreement with a related party to license an exclusive product tracking system. As part of the agreement, the Company advanced the related party $200,000 and entered into a convertible note receivable to secure the advance as collateral. Upon default the convertible note is due on March 5, 2021, carries interest at a rate of 8% and is convertible to common stock of the issuer at the Company’s discretion at $0.03 per share. There was $200,000 advanced as of March 31, 2018 and record as a deposit with related parties.

STOCKHOLDERS' EQUITY

STOCKHOLDERS' EQUITY	6 Months Ended
	Mar. 31, 2018
Notes to Financial Statements
NOTE 5 - STOCKHOLDERS' EQUITY	Series A Convertible Preferred Stock The Company designated 1,850,000 shares of Series A Convertible Preferred Stock (“Series A Preferred Stock”) with a par value of $0.0001 per share. Initially, there will be no dividends due or payable on the Series A Preferred Stock. Any future terms with respect to dividends shall be determined by the Board consistent with the Corporation’s Certificate of Incorporation. Any and all such future terms concerning dividends shall be reflected in an amendment to this Certificate, which the Board shall promptly file or cause to be filed. All shares of the Series A Preferred Stock shall rank (i) senior to the Corporation’s Common Stock and any other class or series of capital stock of the Corporation hereafter created, (ii) pari passu with any class or series of capital stock of the Corporation hereafter created and specifically ranking, by its terms, on par with the Series A Preferred Stock and (iii) junior to any class or series of capital stock of the Corporation hereafter created specifically ranking, by its terms, senior to the Series A Preferred Stock, in each case as to distribution of assets upon liquidation, dissolution or winding up of the Corporation, whether voluntary or involuntary. The Series A Preferred shall have no liquidation preference over any other class of stock. Except as otherwise required by law, holders of Series A Preferred Stock shall have no special voting rights and their consent shall not be required (except to the extent they are entitled to vote with holders of Common Stock or any other class or series of preferred stock) for the taking of any corporate action. Conversion at the Option of the Holder. From 12 months from the date of issuance, each holder of shares of Series A Preferred Stock may, at any time and from time to time, convert (an “Optional Conversion”) each of its shares of Series A Preferred Stock into fully paid and nonassessable shares of Common Stock at a rate equal to 4.9% of the Common Stock. For a period of 18 months after the Preferred is convertible, the conversion price of the Series A Preferred will be subject to adjustment to prevent dilution in the event that the Company issues additional shares at a purchase price less than the applicable conversion price. The conversion price will be subject to adjustment on a weighted basis that takes into account issuances of additional shares. At the expiration of the antidilution period, the conversion rate shall be equal to a conversion rate equal to 4.9% on the Common Stock. For example, if on the date of expiration of the antidilution clause there are 500,000,000 shares of Common Stock issued and outstanding then each Series A Preferred Stock shall convert at a rate of 13.24 common shares for each 1 Series Preferred Share. The Company has evaluated the Series A Preferred Stock in accordance with ASC 815 and has determined their conversion options were for equity and ASC 815 does not apply. The Company has evaluated the Series A Preferred Stock in accordance with FASB ASC Subtopic 470-20 and has determined that there is no beneficial conversion feature that must be accounted. All 1,840,000 outstanding Series A Convertible Stock was converted into 438,753 shares of common stock during the year ended September 30, 2017. The Company has 0 shares of Series A Convertible Stock issued and outstanding as of March 31, 2018 and September 30, 2017. Series B Convertible Preferred Stock The Company designated 5,000,000 shares of Series B Convertible Preferred Stock (“Series B Preferred Stock”) with a par value of $0.0001 per share. Initially, there will be no dividends due or payable on the Series B Preferred Stock. Any future terms with respect to dividends shall be determined by the Board consistent with the Corporation’s Certificate of Incorporation. Any and all such future terms concerning dividends shall be reflected in an amendment to this Certificate, which the Board shall promptly file or cause to be filed. All shares of the Series B Preferred Stock shall rank (i) senior to the Corporation’s Common Stock and any other class or series of capital stock of the Corporation hereafter created, (ii) pari passu with any class or series of capital stock of the Corporation hereafter created and specifically ranking, by its terms, on par with the Series B Preferred Stock and (iii) junior to any class or series of capital stock of the Corporation hereafter created specifically ranking, by its terms, senior to the Series B Preferred Stock, in each case as to distribution of assets upon liquidation, dissolution or winding up of the Corporation, whether voluntary or involuntary. The Series B Preferred shall have no liquidation preference over any other class of stock. Each holder of outstanding shares of Series B Preferred Stock shall be entitled to the number of votes equal to one Common Share. Except as provided by law, or by the provisions establishing any other series of Preferred Stock, holders of Series B Preferred Stock and of any other outstanding series of Preferred Stock shall vote together with the holders of Common Stock as a single class. Each holder of shares of Series B Preferred Stock may, at any time and from time to time, convert (an “Optional Conversion”) each of its shares of Series B Preferred Stock into one (1) fully paid and nonassessable shares of Common Stock. The Company has evaluated the Series B Preferred Stock in accordance with ASC 815 and has determined their conversion options were for equity and ASC 815 does not apply. The Company has evaluated the Series B Preferred Stock in accordance with FASB ASC Subtopic 470-20 and has determined that there is no beneficial conversion feature that must be accounted. The Company has 5,000,000 shares of Series B Convertible Stock issued and outstanding as of March 31, 2018 and September 30, 2017. Series C Convertible Preferred Stock The Company designated 500,000 shares of Series C Convertible Preferred Stock (“Series C Preferred Stock”) with a par value of $0.0001 per share. Initially, there will be no dividends due or payable on the Series C Preferred Stock. Any future terms with respect to dividends shall be determined by the Board consistent with the Corporation’s Certificate of Incorporation. Any and all such future terms concerning dividends shall be reflected in an amendment to this Certificate, which the Board shall promptly file or cause to be filed. All shares of the Series C Preferred Stock shall rank (i) senior to the Corporation’s Common Stock and any other class or series of capital stock of the Corporation hereafter created, (ii) pari passu with any class or series of capital stock of the Corporation hereafter created and specifically ranking, by its terms, on par with the Series B Preferred Stock and (iii) junior to any class or series of capital stock of the Corporation hereafter created specifically ranking, by its terms, senior to the Series B Preferred Stock, in each case as to distribution of assets upon liquidation, dissolution or winding up of the Corporation, whether voluntary or involuntary. In any liquidation, dissolution, or winding up of the Corporation, the holders of the Series C Preferred Stock shall be entitled to receive (a) in preference to the holders of the Common Stock (b) on a pari passu basis to any sum that the holders of the Series B Preferred Stock shall be entitled to receive, but (c) subordinate in preference to any sum that the holders of any shares of any other series of the Corporation's Preferred Stock shall be entitled, an amount equal to $1 per share (subject to appropriate adjustment in the event of any stock dividend, forward stock split, or other similar recapitalization). After payment of such sums, (i) the holders of the Series A Preferred Stock and (ii) the holders of the Common Stock, shall be entitled to receive any remaining assets of the Corporation on a pro rata, as-converted basis assuming conversion of the Series A Preferred Stock into Common Stock at the then- current Conversion Rate. Each holder of outstanding shares of Series C Preferred Stock shall be entitled to the number of votes equal to five (5) Common Shares. Except as provided by law, or by the provisions establishing any other series of Preferred Stock, holders of Series B Preferred Stock and of any other outstanding series of Preferred Stock shall vote together with the holders of Common Stock as a single class. Each holder of shares of Series C Preferred Stock may, at any time and from time to time, convert (an “Optional Conversion”) each of its shares of Series C Preferred Stock into five (5) fully paid and nonassessable shares of Common Stock; provided, however, that any Optional Conversion must involve the issuance of at least 100 shares of Common Stock. In the event of a forward or reverse split, the conversion ratio shall be modified on a pro rata basis to align with the forward or reverse split. The Company has evaluated the Series C Preferred Stock in accordance with ASC 815 and has determined their conversion options were for equity and ASC 815 does not apply. The Company has evaluated the Series C Preferred Stock in accordance with FASB ASC Subtopic 470-20 and has determined that there is no beneficial conversion feature that must be accounted. During the year ended September 30, 2016, the Company issued 300,000 shares of Series C Preferred Stock for the acquisition of Smith Scientific Industries, Inc. and 200,000 shares of Series C Preferred Stock for the acquisition of the assets of Oregon Analytical Services. There were 500,000 shares of Series C Convertible Stock issued and outstanding as of March 31, 2018 and September 30, 2017. Series D Convertible Preferred Stock The Company designated 1,000,000 shares of Series D Convertible Preferred Stock (“Series D Preferred Stock”) with a par value of $0.0001 per share. Initially, there will be no dividends due or payable on the Series D Preferred Stock. Any future terms with respect to dividends shall be determined by the Board consistent with the Corporation’s Certificate of Incorporation. Any and all such future terms concerning dividends shall be reflected in an amendment to this Certificate, which the Board shall promptly file or cause to be filed. All shares of the Series D Preferred Stock shall rank (i) senior to the Corporation’s Common Stock and any other class or series of capital stock of the Corporation hereafter created, (ii) pari passu with any class or series of capital stock of the Corporation hereafter created and specifically ranking, by its terms, on par with the Series B Preferred Stock and (iii) junior to any class or series of capital stock of the Corporation hereafter created specifically ranking, by its terms, senior to the Series B Preferred Stock, in each case as to distribution of assets upon liquidation, dissolution or winding up of the Corporation, whether voluntary or involuntary. As originally issued, in any liquidation, dissolution, or winding up of the Corporation, the holders of the Series D Preferred Stock shall be entitled to receive (a) in preference to the holders of the Common Stock (b) on a pari passu basis to any sum that the holders of the Series B Preferred Stock shall be entitled to receive, but (c) subordinate in preference to any sum that the holders of any shares of any other series of the Corporation's Preferred Stock shall be entitled, an amount equal to $1 per share (subject to appropriate adjustment in the event of any stock dividend, forward stock split, or other similar recapitalization). After payment of such sums, (i) the holders of the Series A Preferred Stock and (ii) the holders of the Common Stock, shall be entitled to receive any remaining assets of the Corporation on a pro rata, as-converted basis assuming conversion of the Series A Preferred Stock into Common Stock at the then- current Conversion Rate. On July 31, 2017, the Company amended its articles of incorporation such that the Series D Preferred Stock shall have no liquidation preference over any other class of stock. Each holder of outstanding shares of Series D Preferred Stock shall be entitled to the number of votes equal to two hundred fifty (250) Common Shares. Except as provided by law, or by the provisions establishing any other series of Preferred Stock, holders of Series B Preferred Stock and of any other outstanding series of Preferred Stock shall vote together with the holders of Common Stock as a single class. Each holder of shares of Series D Preferred Stock may, at any time and from time to time, convert (an “Optional Conversion”) each of its shares of Series D Preferred Stock into 2.5 fully paid and nonassessable shares of Common Stock; provided, however, that any Optional Conversion must involve the issuance of at least 500 shares of Common Stock. In the event of a forward or reverse split, the conversion ratio shall be modified on a pro rata basis to align with the forward or reverse split. The Company has evaluated the Series D Preferred Stock in accordance with ASC 815 and has determined their conversion options were for equity and ASC 815 does not apply. The Company has evaluated the Series D Preferred Stock in accordance with FASB ASC Subtopic 470-20 and has determined that there is no beneficial conversion feature that must be accounted. During the year ended September 30, 2016, the Company issued 48,000 shares of Series D Preferred Stock for cash proceeds of $48,000. During the year ended September 30, 2017, the Company issued 114,500 shares of Series D Preferred Stock for cash proceeds of $114,500 and 670,000 shares of Series D Preferred Stock, valued at $670,000, in conjunction with certain acquisitions. During the six months ended March 31, 2018, the Company accepted five separate conversion notices from Series D Preferred Stockholders resulting in a total of 700,000 shares of common stock being issued for the conversion of 280,000 shares of Series D Preferred Stock. There were 552,500 and 832,500 shares of Series D Convertible Stock issued and outstanding as March 31, 2018 and September 30, 2017, respectively. Common Stock The Company has authorized to issue up to 1,000,000,000 shares of common stock with a par value of $0.0001 per share. During the year ended September 30, 2017, the Company issued 333,949 common shares valued at $537,515 for services; 438,753 common shares for the conversion of 1,840,000 shares of Series A Preferred Stock; 112,000 common shares for cash proceeds of $112,000; 93,691 common shares valued at $211,071 under its employee equity incentive plan; 10,000 common shares for the settlement of $11,400 of accounts payable; 1,755 common share due to the rounding impacts of the 1:100 reverse stock split; 1,142,892 common shares for the conversion of $765,050 of outstanding principal on convertible notes payable; 53,304 for the conversion of $30,975 of convertible accrued interest; 40,935 common shares for the settlement of non-convertible debt totaling $46,666 and 5,000 common shares valued at $7,651 as a settlement. All conversions of outstanding principal and accrued interest on convertible notes payable were done so at contractual terms. During the six months ended March 31, 2018, the Company issued 207,750 common shares valued at $254,720 for services; 700,000 common shares for the conversion of 280,000 shares of Series D Preferred Stock; 1,270,000 common shares for cash proceeds of $508,000; 57,000 common shares valued at $75,755 under its employee equity incentive plan under which a total expense of $166,647 was recorded; 37,500 common shares for the settlement of $15,000 of accounts payable; 1,869,650 common shares for the conversion of $703,215 of outstanding principal on convertible notes payable; 74,412 for the conversion of $27,270 of convertible accrued interest; 324,000 common shares for the settlement of non-convertible debt and interest totaling $122,157; 125,000 common shares for the settlement of non-convertible related party debt totaling $50,000 and 670,271 common shares valued at $1,414,907 for debt issue costs from a capital raise. All conversions of outstanding principal and accrued interest on convertible notes payable were done so at contractual terms. There were 16,068,505 and 10,732,922 shares of common stock issued and outstanding at March 31, 2018 and September 30, 2017, respectively.

LOANS PAYABLE

LOANS PAYABLE	6 Months Ended
	Mar. 31, 2018
Notes to Financial Statements
NOTE 6 - LOANS PAYABLE	The Company had the following loans payable outstanding as of March 31, 2018 and September 30, 2017: March 31, 2018 September 30, 2017 On March 16, 2017, the Company executed notes payable for the purchase of three vehicles. The notes carry interest at 6.637% annually and mature on March 31, 2023. $ 65,691 $ 71,039 On August 1, 2017, the Company entered into a note payable totaling $500,000 for the acquisition of Viridis (see note 3). The note carries interest at 8% annually and is due on July 1, 2018. 500,000 500,000 On September 6, 2017, the Company entered into a note payable totaling $1,000,000 for the purchase of an outstanding note receivable. The note carries interest at 8% annually and is due on July 6, 2018. 500,000 1,000,000 On August 31, 2017, the Company executed a note payable for $120,000 of which $20,000 was an original issue discount resulting in cash proceeds of $100,000. The note carries interest at 8% annually and is due on March 3, 2018. - 120,000 1,065,691 1,691,039 Less: unamortized original issue discounts (37,024 ) (127,662 ) Total loans payable 1,028,667 1,563,377 Less: current portion of loans payable 975,192 1,503,545 Long-term portion of loans payable $ 53,475 $ 59,832 As discussed in Note 10 – Acquisitions As of March 31, 2018 and September 30, 2017, the Company accrued interest of $39,682 and $12,625, respectively.

CONVERTIBLE NOTES PAYABLE

CONVERTIBLE NOTES PAYABLE	6 Months Ended
	Mar. 31, 2018
Notes to Financial Statements
NOTE 7 - CONVERTIBLE NOTES PAYABLE	The Company has entered into convertible notes payable that convert to common stock of the Company at variable conversion prices. As further discussed in Note 9 – Derivative Liability The following table summarizes all convertible notes outstanding as of September 30, 2017: Holder Issue Date Due Date Principal Unamortized Debt Discount Carrying Value Accrued Interest Noteholder 1 3/2/2017 3/2/2018 $ 125,000 $ (38,112 ) $ 86,888 $ 5,671 Noteholder 1 7/14/2017 7/14/2018 275,600 (11,795 ) 263,805 4,712 Noteholder 1 8/14/2017 8/14/2018 275,600 (13,068 ) 262,532 2,839 Noteholder 4 3/2/2017 3/2/2018 69,000 (50,009 ) 18,991 7,187 Noteholder 4 6/5/2017 3/2/2018 125,000 (70,833 ) 54,167 3,205 Noteholder 4 7/14/2017 7/14/2018 275,600 (11,795 ) 263,805 4,470 Noteholder 4 8/14/2017 8/14/2018 275,600 (13,068 ) 262,532 2,597 $ 1,421,400 $ (208,680 ) $ 1,212,720 $ 30,681 The following table summarizes all convertible notes outstanding as of March 31, 2018: Holder Issue Date Due Date Principal Unamortized Debt Discount Carrying Value Accrued Interest Noteholder 1 7/14/2017 7/14/2018 $ 40,300 $ (26,071 ) $ 14,229 $ 6,297 Noteholder 1 8/14/2017 8/14/2018 275,600 (200,290 ) 75,310 13,815 Noteholder 4 7/14/2017 7/14/2018 126,685 (73,348 ) 53,337 15,683 Noteholder 4 8/14/2017 8/14/2018 275,600 (200,289 ) 75,311 13,815 Noteholder 5 1/1/2018 6/30/2018 500,000 - 500,000 - $ 1,218,185 $ (499,998 ) $ 718,187 $ 49,610 Noteholder 1 On March 2, 2017, the Company sold and issued a Convertible Promissory Note to an unrelated party, for the principal amount of $125,000 resulting in cash proceeds to the Company of $125,000 pursuant to the terms of a Securities Purchase Agreement of even date therewith. The Note, together with accrued interest at the annual rate of 8%, is due on March 2, 2018. The Note is convertible into the Company's common stock commencing 180 days from the date of issuance at a conversion price equal to 65% of the lowest trade price of the Company's common stock for the twenty prior trading days including the date of conversion. During the six months ended March 31, 2018 , the holder elected to convert a total of $125,000 of principal in exchange for 325,562 common shares. There was $0 and $125,000 of principal and $0 and $7,397 of accrued interest due at March 31, 2018 and September 30, 2017, respectively. On July 14, 2017, the Company sold and issued a Convertible Promissory Note to an unrelated party, for the principal amount of $275,600 of which $15,600 was an original issue discount and $10,000 was paid directly to third parties resulting in cash proceeds to the Company of $250,000 pursuant to the terms of a Securities Purchase Agreement of even date therewith. The Note, together with accrued interest at the annual rate of 8%, is due on July 14, 2018. The Note is convertible into the Company's common stock commencing 180 days from the date of issuance at a conversion price equal to 75% of the lowest trade price of the Company's common stock for the fifteen prior trading days including the date of conversion. During the six months ended March 31, 2018, the holder elected to convert $235,300 of outstanding principal and $9,386 of accrued interest to 593,345 and 23,669 shares of common stock. There was $40,300 of principal and $6,297 and $4,712 of accrued interest due at March 31, 2018 and September 30, 2017, respectively. On August 14, 2017, the Company sold and issued a Convertible Promissory Note to an unrelated party, for the principal amount of $275,600 of which $15,600 was an original issue discount and $10,000 was paid directly to third parties resulting in cash proceeds to the Company of $250,000 pursuant to the terms of a Securities Purchase Agreement of even date therewith. The Note, together with accrued interest at the annual rate of 8%, is due on August 14, 2018. The Note is convertible into the Company's common stock commencing 180 days from the date of issuance at a conversion price equal to 75% of the lowest trade price of the Company's common stock for the fifteen prior trading days including the date of conversion. There was $275,600 of principal and $13,815 and $2,839 of accrued interest due at March 31, 2018 and September 30, 2017, respectively. Noteholder 4 On March 2, 2017, the Company sold and issued a Convertible Promissory Note to an unrelated party, for the principal amount of $125,000 resulting in cash proceeds to the Company of $125,000 pursuant to the terms of a Securities Purchase Agreement of even date therewith. The Note, together with accrued interest at the annual rate of 8%, is due on March 2, 2018. The Note is convertible into the Company's common stock commencing 180 days from the date of issuance at a conversion price equal to 65% of the lowest trade price of the Company's common stock for the twenty prior trading days including the date of conversion. During the year ended September 30, 2017, the holder elected to convert a total of $56,000 of principal in exchange for 111,538 shares of common stock. Additionally, during the six months ended March 31, 2018, the holder elected to convert a total of $69,000 of principal in exchange for 219,258 shares of common stock. There was $0 and $69,000 of principal and $0 and $7,187 of accrued interest due at March 31, 2018 and September 30, 2017, respectively. On March 2, 2017, the Company sold a Convertible Promissory Note to an unrelated party, for the principal amount of $125,000 resulting in cash proceeds to the Company of $125,000 pursuant to the terms of a Securities Purchase Agreement of even date therewith which was funded on June 5, 2017. The Note, together with accrued interest at the annual rate of 8%, is due on March 2, 2018. The Note is convertible into the Company's common stock upon funding at a conversion price equal to 65% of the lowest trade price of the Company's common stock for the fifteen prior trading days including the date of conversion. During the six months ended March 31, 2018, the holder elected to convert a total of $125,000 or principal in exchange for 355,973 shares of common stock. There was $0 and $125,000 of principal and $0 and $3,205 of accrued interest due at March 31, 2018 and September 30, 2017, respectively. On July 14, 2017, the Company sold and issued a Convertible Promissory Note to an unrelated party, for the principal amount of $275,600 of which $15,600 was an original issue discount and $10,000 was paid directly to third parties resulting in cash proceeds to the Company of $250,000 pursuant to the terms of a Securities Purchase Agreement of even date therewith. The Note, together with accrued interest at the annual rate of 8%, is due on July 14, 2018. The Note is convertible into the Company's common stock commencing 180 days from the date of issuance at a conversion price equal to 75% of the lowest trade price of the Company's common stock for the fifteen prior trading days including the date of conversion. During the six months ended March 31, 2018, the holder elected to convert $148,915 of outstanding principal to 375,512 shares of common stock. There was $126,685 of principal and $15,683 and $4,712 of accrued interest due at March 31, 2018 and September 30, 2017, respectively. On August 14, 2017, the Company sold and issued a Convertible Promissory Note to an unrelated party, for the principal amount of $275,600 of which $15,600 was an original issue discount and $10,000 was paid directly to third parties resulting in cash proceeds to the Company of $250,000 pursuant to the terms of a Securities Purchase Agreement of even date therewith. The Note, together with accrued interest at the annual rate of 8%, is due on August 14, 2018. The Note is convertible into the Company's common stock commencing 180 days from the date of issuance at a conversion price equal to 75% of the lowest trade price of the Company's common stock for the fifteen prior trading days including the date of conversion. There was $275,600 of principal and $13,815 and $2,896 of accrued interest due at March 31, 2018 and September 30, 2017 respectively. Noteholder 5 On January 1, 2018, the Company entered into a convertible note payable totaling $500,000 in exchange for a 60% interest in C3 Labs, LLC. The note bears no interest, matures on June 30, 2018 and automatically converts to common stock at $0.75 per share on the maturity date. In the event the average trading price of the Company’s common stock during the five days prior to maturity is less than $0.75 per share, the Company will pay the noteholder the difference between $0.75 and the average trading price during the preceding five days per share converted in cash. The Company may prepay the outstanding principal in whole or in part before maturity without penalty. There was $500,000 and $0 of principal due as of March 31, 2018 and September 30, 2017, respectively.

CONVERTIBLE DEBENTURES

CONVERTIBLE DEBENTURES	6 Months Ended
	Mar. 31, 2018
Notes to Financial Statements
NOTE 8 - CONVERTIBLE DEBENTURES	On January 29, 2018, the Company issued a total of 5,973 units of 8% unsecured convertible debentures. Each unit consists of one convertible debenture with a principal face value of $1,000 and 250 warrants. The gross proceeds were $5,973,000. Each warrant entitles the holder thereof to purchase one additional common share of the Company at an exercise price of $0.80 per warrant for a period of 24 months. The convertible debentures have a maturity date of 36 months from issuance. Simple interest will be paid at a rate of 8% per annum in arrears until maturity or until conversion. The principal amount of the debentures and any accrued interest thereon are convertible at the option of the holder into common shares of the Company at any time at a conversion price of $0.60 per share. In addition to the warrants associated with the convertible debentures, the Company issued an additional 597,300 warrants to purchase common stock of the Company as offering costs representing an equivalent of 6% of the fully converted debentures. The warrants are exercisable at $0.60 per share for a period of two years. The Company also issued three separate debentures under the same terms for additional cash proceeds of $610,000. The additional debentures carry an additional 152,500 warrants to purchase additional common shares of the Company at $0.80 per share. Additionally, the outstanding principal and interest may be converted to common stock of the Company at $0.60 per share. Associated with the issuance of the convertible debentures, the Company incurred cash based issuance costs of $702,963, issued common shares valued at $1,414,907 and warrants to purchase additional shares of common stock valued at $1,265,385 for total debt issuance costs of $3,383,255. The debt issuance costs were recorded as a discount to the carrying value of the convertible debentures. The warrants associated with the debt issue costs were valued using a Black-Scholes model with the following assumptions: Expected term of options granted 2.00 years Expected volatility 223 % Risk-free interest rate 2.49 % Expected dividend yield 0 % The Company separately assessed the value of the detachable warrants and conversion features of the convertible debentures. The Company separately valued the detachable warrants issued with the convertible debentures at $3,351,160 using a Black-Scholes model with the following assumptions: Expected term of options granted 2.00 years Expected volatility 211-223 % Risk-free interest rate 2.09-2.25 % Expected dividend yield 0 % Additionally, the outstanding principal on convertible debentures totaling $6,583,000 may be converted into common stock of the Company at $0.60 per share for a total of 10,971,667 shares. Due to the variable conversion features of the outstanding convertible notes payable as discussed in Note 7 – Convertible Notes Payable As of March 31, 2018 the Company has amortized $353,889 of the total outstanding debt discount leaving an unamortized debt discount of $6,229,111. The debt discount will be amortized to interest expense over the expected life of the note. There was $6,583,000 of principal and accrued interest totaling $86,454 outstanding as of March 31, 2018.

DERIVATIVE LIABILITY

DERIVATIVE LIABILITY	6 Months Ended
	Mar. 31, 2018
Notes to Financial Statements
NOTE 9 - DERIVATIVE LIABILITY	As of March 31, 2018 and September 30, 2017, Company had a derivative liability balance of $3,123,223 and $294,637 on the balance sheets and recorded a gain of $1,780,769 and $1,794,091 from derivative liability fair value adjustments during the three and six months ended March 31, 2018. The derivative liability activity comes from convertible notes payable as follows: As discussed in Note 7 – Convertible Notes Payable The embedded derivative for the note is carried on the Company’s balance sheet at fair value. The derivative liability is marked-to-market each measurement period and any unrealized change in fair value is recorded as a component of the income statement and the associated fair value carrying amount on the balance sheet is adjusted by the change. The Company fair values the embedded derivative using the Black-Scholes option pricing model. The aggregate fair value of the derivative at the issuance date of the note was $107,768 which was recorded as a derivative liability on the balance sheet. The Company recorded a debt discount of $107,768 which was up to the face value of the convertible note. During the year ended September 30, 2017 and six months ended March 31, 2018, the noteholder elected to convert a total of $56,000 and $69,000 of principal. At March 31, 2018, the Company marked-to-market the fair value of the derivative liabilities related to notes and determined an aggregate fair value of $0 and recorded a $3,312 gain from change in fair value and $63,225 due to conversion for the six months ended March 31, 2018. The fair value of the embedded derivatives for the notes was determined using a Monte Carlo simulation model based on the following assumptions: (1) expected volatility of 110%, (2) risk-free interest rate of 1.3%, and (3) expected life of 0.26 of a year. As discussed in Note 7 – Convertible Notes Payable The embedded derivative for the note is carried on the Company’s balance sheet at fair value. The derivative liability is marked-to-market each measurement period and any unrealized change in fair value is recorded as a component of the income statement and the associated fair value carrying amount on the balance sheet is adjusted by the change. The Company fair values the embedded derivative using the Black-Scholes option pricing model. The aggregate fair value of the derivative at the issuance date of the note was $107,785 which was recorded as a derivative liability on the balance sheet. The Company recorded a debt discount of $107,785 which was up to the face value of the convertible note. During the six months ended March 31, 2018, the noteholder elected to convert a total of $125,000 of principal. At March 31, 2018, the Company marked-to-market the fair value of the derivative liabilities related to notes and determined an aggregate fair value of $0 and recorded a $4,043 gain from change in fair value and $111,758 due to conversion for the six months ended March 31, 2018. The fair value of the embedded derivatives for the notes was determined using a Monte Carlo simulation model based on the following assumptions: (1) expected volatility of 111%, (2) risk-free interest rate of 1.3%, and (3) expected life of 0.25 of a year. As discussed in Note 7 – Convertible Notes Payable The embedded derivative for the note is carried on the Company’s balance sheet at fair value. The derivative liability is marked-to-market each measurement period and any unrealized change in fair value is recorded as a component of the income statement and the associated fair value carrying amount on the balance sheet is adjusted by the change. The Company fair values the embedded derivative using the Black-Scholes option pricing model. The aggregate fair value of the derivative at the issuance date of the note was $157,523 which was recorded as a derivative liability on the balance sheet. The Company recorded a debt discount of $125,000 which was up to the face value of the convertible note with the excess fair value at initial measurement of $32,523 being recognized as a loss on derivative fair value measurement. During the six months ended March 31, 2018, the noteholder elected to convert a total of $125,000 of principal. At March 31, 2018, the Company marked-to-market the fair value of the derivative liabilities related to notes and determined an aggregate fair value of $0 and recorded a $5,967 gain from change in fair value and $106,332 due to conversion for the six months ended March 31, 2018. The fair value of the embedded derivatives for the notes was determined using a Monte Carlo simulation model based on the following assumptions: (1) expected volatility of 113%, (2) risk-free interest rate of 1.3%, and (3) expected life of 0.18 of a year. As discussed in Note 7 – Convertible Notes Payable The embedded derivative for the note is carried on the Company’s balance sheet at fair value. The derivative liability is marked-to-market each measurement period and any unrealized change in fair value is recorded as a component of the income statement and the associated fair value carrying amount on the balance sheet is adjusted by the change. The Company fair values the embedded derivative using a Monte Carlo Simulation. The aggregate fair value of the derivative at the issuance date of the note was $419,722 which was recorded as a derivative liability on the balance sheet. The Company recorded a debt discount of $260,000 which was up to the face value of the convertible note with the excess fair value at initial measurement of $159,722 being recognized as a loss on derivative fair value measurement. During the six months ended March 31, 2018, the noteholder elected to convert a total of $148,915 of principal. At March 31, 2018, the Company marked-to-market the fair value of the derivative liabilities related to notes and determined an aggregate fair value of $123,338 and recorded a $69,346 gain from change in fair value and $227,038 due to conversion for the six months ended March 31, 2018. The fair value of the embedded derivatives for the notes was determined using a Monte Carlo simulation model based on the following assumptions: (1) expected volatility of 128%, (2) risk-free interest rate of 1.76%, and (3) expected life of 0.29 of a year. As discussed in Note 7 – Convertible Notes Payable The embedded derivative for the note is carried on the Company’s balance sheet at fair value. The derivative liability is marked-to-market each measurement period and any unrealized change in fair value is recorded as a component of the income statement and the associated fair value carrying amount on the balance sheet is adjusted by the change. The Company fair values the embedded derivative a Monte Carlo simulation. The aggregate fair value of the derivative at the issuance date of the note was $419,796 which was recorded as a derivative liability on the balance sheet. The Company recorded a debt discount of $260,000 which was up to the face value of the convertible note with the excess fair value at initial measurement of $159,796 being recognized as a loss on derivative fair value measurement. During the six months ended March 31, 2018, the noteholder elected to convert a total of $235,300 of principal. At March 31, 2018, the Company marked-to-market the fair value of the derivative liabilities related to notes and determined an aggregate fair value of $38,442 and recorded a $7,253 gain from change in fair value and $374,101 due to conversion for the six months ended March 31, 2018. The fair value of the embedded derivatives for the notes was determined using a Monte Carlo simulation model based on the following assumptions: (1) expected volatility of 128%, (2) risk-free interest rate of 1.76%, and (3) expected life of 0.29 of a year. As discussed in Note 7 – Convertible Notes Payable The embedded derivative for the note is carried on the Company’s balance sheet at fair value. The derivative liability is marked-to-market each measurement period and any unrealized change in fair value is recorded as a component of the income statement and the associated fair value carrying amount on the balance sheet is adjusted by the change. The Company fair values the embedded derivative using a Monte Carlo Simulation. The aggregate fair value of the derivative at the issuance date of the note was $330,278 which was recorded as a derivative liability on the balance sheet. The Company recorded a debt discount of $260,000 which was up to the face value of the convertible note with the excess fair value at initial measurement of $70,278 being recognized as a loss on derivative fair value measurement. At March 31, 2018, the Company marked-to-market the fair value of the derivative liabilities related to notes and determined an aggregate fair value of $248,420 and recorded a $81,858 gain from change in fair value for the six months ended March 31, 2018. The fair value of the embedded derivatives for the notes was determined using a Monte Carlo simulation model based on the following assumptions: (1) expected volatility of 128%, (2) risk-free interest rate of 1.83%, and (3) expected life of 0.37 of a year. As discussed in Note 7 – Convertible Notes Payable The embedded derivative for the note is carried on the Company’s balance sheet at fair value. The derivative liability is marked-to-market each measurement period and any unrealized change in fair value is recorded as a component of the income statement and the associated fair value carrying amount on the balance sheet is adjusted by the change. The Company fair values the embedded derivative using a Monte Carlo Simulation. The aggregate fair value of the derivative at the issuance date of the note was $329,356 which was recorded as a derivative liability on the balance sheet. The Company recorded a debt discount of $260,000 which was up to the face value of the convertible note with the excess fair value at initial measurement of $69,356 being recognized as a loss on derivative fair value measurement. At March 31, 2018, the Company marked-to-market the fair value of the derivative liabilities related to notes and determined an aggregate fair value of $299,373 and recorded a $29,983 gain from change in fair value for the six months ended March 31, 2018. The fair value of the embedded derivatives for the notes was determined using a Monte Carlo simulation model based on the following assumptions: (1) expected volatility of 128%, (2) risk-free interest rate of 1.83%, and (3) expected life of 0.37 of a year. As discussed in Note 8 – Convertible Debentures The derivative for the warrants is carried on the Company’s balance sheet at fair value. The derivative liability is marked-to-market each measurement period and any unrealized change in fair value is recorded as a component of the income statement and the associated fair value carrying amount on the balance sheet is adjusted by the change. The Company fair values the embedded derivative using the Black-Scholes option pricing model. The aggregate fair value of the derivative at the issuance date of the warrants was $4,616,545 which was recorded as a derivative liability on the balance sheet. The Company recorded a debt discount of $4,465,131 which was up to the face value of the convertible debentures with the excess fair value at initial measurement of $151,414 being recognized as a loss on derivative fair value measurement. At March 31, 2018, the Company marked-to-market the fair value of the derivative liabilities related to warrants and determined an aggregate fair value of $2,413,650 and recorded a $2,202,895 gain from change in fair value for the six months ended March 31, 2018. The fair value of the embedded derivatives for the notes was determined using a Black-Scholes option pricing model based on the following assumptions: (1) expected volatility of 194% - 205%, (2) risk-free interest rate of 1.83%, (3) exercise prices of $0.60 - $0.80, and (4) expected lives of 1.84 – 1.88 of a year. The following table summarizes the derivative liabilities included in the balance sheet at September 30, 2017: Fair Value of Embedded Derivative Liabilities: Balance, September 30, 2016 $ 775,246 Initial measurement of derivative liabilities 1,312,384 Change in fair market value (195,907 Write off due to conversion (1,597,086 ) Balance, September 30, 2017 $ 294,637 The following table summarizes the derivative liabilities included in the balance sheet at March 31, 2018: Fair Value of Embedded Derivative Liabilities: Balance, September 30, 2017 $ 294,637 Initial measurement of derivative liabilities 6,115,697 Change in fair market value (2,404,657 ) Write off due to conversion (882,454 ) Balance, March 31, 2018 $ 3,123,223 The following table summarizes the gain (loss) on derivative liability included in the income statement for the three and six months ended March 31, 2018 and 2017, respectively. Three Months Ended March 31, Six Months Ended March 31, 2018 2017 2018 2017 Day one loss due to derivatives on convertible debt $ (610,566 ) $ (64,492 ) $ (610,566 ) $ (352,206 ) Change in fair value of derivatives 2,391,335 (20,543 ) 2,404,657 160,928 Total derivative expense (gain) $ 1,780,769 $ (85,035 ) $ 1,794,091 $ (191,278 )

ACQUISITIONS

ACQUISITIONS	6 Months Ended
	Mar. 31, 2018
Notes to Financial Statements
NOTE 10 - ACQUISITIONS	On January 1, 2018, the Company completed its acquisition of C3 Labs, LLC (“C3 Labs”). In consideration of a 60% ownership, the Company issued a $500,000 convertible note payable which carries no interest and matures on June 30, 2018. Upon maturation, the note will convert to common stock of the Company at $0.75 per share. Additionally, the Company issued a $100,000 note payable due on March 31, 2018 which bears no interest. The Company has been granted two options to purchase additional interest of C3 Labs subject to the following terms and conditions. (a) 30% Option. Effective as of Closing and terminating the date three (3) years from the Closing Date, the C3 Members hereby collectively grant EVIO the right to ratably purchase from the C3 Members an aggregate of 30% of the Interests in C3 LABS following the issuance of 60% of the Interests to EVIO. EVIO may exercise its option by providing C3 LABS and the C3 Members written notice of its intent to exercise the option. The C3 Members shall have three (3) days following the date of such notice to execute assignments of Interests totaling 30% of the then outstanding membership interests in C3 LABS in favor of EVIO California. If EVIO should elect to exercise its option within nine (9) months from the Closing Date, the exercise price for the 30% of Interests shall be $450,000.00, to be paid in cash or EVIO’s common stock, as agreed by the C3 Members. If EVIO does not exercise the option within nine (9) months from the Closing Date, the exercise price shall be set by mutual agreement between the parties or, if no such agreement can be reached, as determined by an independent third-party valuation by an appraiser agreed to by the parties. (b) 10% Option. Effective as of three (3) years after the Closing Date and terminating the date twenty four (24) months therefrom, the C3 Members hereby collectively grant EVIO the right to ratably purchase from the C3 Members an aggregate of 10% of the then outstanding Interests in C3 LABS (comprising the remaining Interests not owned by EVIO). EVIO may exercise its option by providing C3 LABS and the C3 Members written notice of its intent to exercise the option. The C3 Members shall have three (3) days following the date of such notice to execute assignments of Interests totaling 10% of the then outstanding membership interests in C3 LABS in favor of EVIO. Upon notice of its intent to exercise the option granted hereby, the exercise price shall be set by mutual agreement between the parties or, if no such agreement can be reached, as determined by an independent third-party valuation by an appraiser agreed to by the parties. The Company applied the acquisition method to the business combination and valued each of the assets acquired (cash, accounts receivable, security deposits, customer lists, certain testing licenses, equipment and non-compete agreements) and liabilities assumed (accounts payable and deferred rent payable) at fair value as of the acquisition date. The cash, accounts receivable, security deposits, accounts payable and deferred rent payable were deemed to be recorded at fair value as of the acquisition date. The Company determined the fair value of the equipment to be historical net book value. The preliminary allocation of the purchase price was based on estimates of the fair value of the assets and liabilities assumed based on provisional amounts. The allocation of the excess purchase price is not final and the amounts allocated to intangible assets are subject to change pending the completion of final valuations of certain assets and liabilities. Under the purchase agreement, the Company issued a $100,000 promissory note and a $500,000 convertible promissory note for total consideration of $600,000 in exchange for a 60% interest. The following table shows the estimated fair values of the assets acquired and liabilities assumed at the date of acquisition: ASSETS ACQUIRED Cash $ 20,468 Accounts receivable 5,110 Other current assets 3,461 Security deposits 20,000 Equipment 244,875 License 247,000 Customer list 112,000 Non-compete agreement 88,000 Goodwill 291,697 TOTAL ASSETS ACQUIRED $ 1,032,611 LIABILITIES ASSUMED Accounts payable 4,314 Deferred rent 28,297 TOTAL LIABILITIES ASSUMED 32,611 Non-controlling interest (400,000 ) NET ASSETS ACQUIRED $ 600,000 The license and customer list will be amortized over 7 years and non-compete agreement over 5 years From the date of acquisition on January 1, 2018 to March 31, 2018, C3 Labs generated total revenues of $34,555.

INDUSTRY SEGMENTS

INDUSTRY SEGMENTS	6 Months Ended
	Mar. 31, 2018
Notes to Financial Statements
NOTE 11 - INDUSTRY SEGMENTS	This summary reflects the Company's current segments, as described below. Corporate The parent Company provides overall management and corporate reporting functions for the entire organization. Consulting The Company provides advisory, licensing and compliance services to the cannabis industry. Consulting clients are located in states that have state managed medical and/or recreational programs. EVIO assists these companies with license applications, business planning, state compliance and ongoing operational support. Testing Services The Company provides analytical testing services to the cannabis industry under the EVIO Labs brand. As of March 31, 2018, EVIO Labs has seven operating labs. EVIO Labs clients are located in Oregon, California and Massachusetts and consist of growers, processors and dispensaries. Operating under the rules of the appropriate state regulating body, EVIO Labs certifies products have been tested and are free from pesticides and other containments before resale to patients and consumers. Six months ended March 31, 2018 Corporate Consulting Services Testing Services Total Consolidated Revenue $ - $ 102,816 $ 1,576,360 $ 1,679,176 Segment income (loss) from operations (1,459,932 ) (975,276 ) (594,792 ) (3,030,000 ) Total assets 4,262,523 217,092 6,828,299 11,307,914 Capital expenditures - (1,038 ) (530,476 ) (531,514 ) Depreciation and amortization - 7,171 218,804 225,975 Six months ended March 31, 2017 Corporate Consulting Services Testing Services Total Consolidated Revenue $ - $ 187,175 $ 1,314,004 $ 1,501,179 Segment income (loss) from operations (378,704 ) 4,648 (299,118 ) (673,174 ) Total assets 93,328 90,600 3,811,833 3,995,761 Capital expenditures - (1,038 ) (44,726 ) (45,764 ) Depreciation and amortization - 11,947 108,783 120,730 Three months ended March 31, 2018 Corporate Consulting Services Testing Services Total Consolidated Revenue $ - $ 43,300 $ 689,011 $ 732,311 Segment income (loss) from operations (1,264,646 ) (618,691 ) (479,603 ) (2,362,940 ) Total assets 4,262,523 217,092 6,828,299 11,307,914 Capital expenditures - - (524,562 ) (524,562 ) Depreciation and amortization - 1,197 138,278 139,475 Three months ended March 31, 2017 Corporate Consulting Services Testing Services Total Consolidated Revenue $ - $ 87,297 $ 745,426 $ 832,723 Segment income (loss) from operations (163,362 ) (7,717 ) (110,779 ) (281,858 ) Total assets 93,328 90,600 3,811,833 3,995,761 Capital expenditures - - (19,450 ) (19,450 ) Depreciation and amortization - 5,973 61,920 67,893

STOCK OPTIONS AND WARRANTS

STOCK OPTIONS AND WARRANTS	6 Months Ended
	Mar. 31, 2018
Notes to Financial Statements
NOTE 12 - STOCK OPTIONS AND WARRANTS	The following table summarizes all stock option and warrant activity for the year ended September 30, 2017 and the six months ended March 31, 2018: Shares Weighted- Average Exercise Price Per Share Outstanding, September 30, 2016 315,000 $ 0.449 Granted 380,000 1.295 Exercised - - Forfeited (40,000 ) 1.075 Expired - - Outstanding, September 30, 2017 655,000 $ 0.902 Shares Weighted- Average Exercise Price Per Share Outstanding, September 30, 2017 655,000 $ 0.902 Granted 3,948,050 0.763 Exercised - - Forfeited (70,000 ) 0.891 Expired - - Outstanding, March 31, 2018 4,533,050 $ 0.781 The following table discloses information regarding outstanding and exercisable options and warrants at September 30, 2017: Outstanding Exercisable Exercise Prices Number of Option Shares Weighted Average Exercise Price Weighted Average Remaining Life (Years) Number of Option Shares Weighted Average Exercise Price $ 0.400 150,000 $ 0.400 3.88 75,000 $ 0.400 $ 0.500 155,000 $ 0.500 3.88 77,500 $ 0.500 $ 1.260 270,000 $ 1.260 4.75 - $ 1.260 $ 1.386 60,000 $ 1.386 4.75 - $ 1.386 $ 1.300 10,000 $ 1.300 4.05 2,500 $ 1.300 $ 1.666 10,000 $ 1.666 4.84 - 1.666 Total 655,000 $ 0.902 4.33 155,000 $ 0.465 In determining the compensation cost of the stock options granted, the fair value of each option grant has been estimated on the date of grant using the Black-Scholes option pricing model. The assumptions used in these calculations are summarized as follows: September 30, 2017 Expected term of options granted 5 years Expected volatility 2.68 % Risk-free interest rate 1.89 % Expected dividend yield 0 % The following table discloses information regarding outstanding and exercisable options and warrants at March 31, 2018: Outstanding Exercisable Exercise Prices Number of Option Shares Weighted Average Exercise Price Weighted Average Remaining Life (Years) Number of Option Shares Weighted Average Exercise Price $ 0.400 120,000 $ 0.400 3.38 90,000 $ 0.400 $ 0.500 165,000 $ 0.500 3.45 121,250 $ 0.500 $ 0.600 597,300 $ 0.600 1.83 597,300 $ 0.600 $ 0.650 145,000 $ 0.650 4.57 - $ 0.650 $ 0.800 3,195,750 $ 0.800 3.24 2,420,750 $ 0.800 $ 1.260 230,000 $ 1.260 4.25 57,500 $ 1.260 $ 1.300 10,000 $ 1.300 3.56 5,000 $ 1.300 $ 1.386 60,000 $ 1.386 4.25 15,000 $ 1.386 $ 1.666 10,000 $ 1.666 4.34 2,500 $ 1.666 Total 4,533,050 $ 0.781 3.82 3,309,300 $ 0.754 In determining the compensation cost of the stock options granted, the fair value of each option grant has been estimated on the date of grant using the Black-Scholes option pricing model. The assumptions used in these calculations are summarized as follows: March 31, 2018 Expected term of options granted 4.98 – 5.00 years Expected volatility 251-256 % Risk-free interest rate 2.01–2.25 % Expected dividend yield 0 % The Company recognized stock option expense of $986,203 and $21,749 and $1,067,768 and $42,165 during the three and six months ended March 31, 2018 and 2017, respectively. There was $1,014,765 of unrecognized stock based compensation expense as of March 31, 2018.

COMMETTMENTS AND CONTINGECIES

COMMETTMENTS AND CONTINGECIES	6 Months Ended
	Mar. 31, 2018
Notes to Financial Statements
NOTE 13 - COMMETTMENTS AND CONTINGECIES	From time to time, we may become involved in various lawsuits and legal proceedings which arise in the ordinary course of business. However, litigation is subject to inherent uncertainties, and an adverse result in these or other matters may arise from time to time that may harm our business. We are currently not aware of any such legal proceedings or claims that we believe will have, individually or in the aggregate, a material adverse effect on our business, financial condition or operating results. During the year ended September 30, 2017, the Company purchased a software license for $200,000 in cash. The Company relied on the representation of the seller regarding the assignability of the license. However, independent verification of the assignability was not obtained. As a result, the Company recognized a $200,000 impairment loss on the write off of the asset. There have been no additional amounts accrued for potential losses related to the assignability of the license. The Company has entered into various office and laboratory leases as well as a long term operating lease. Future minimum rental payments under the terms of the lease are: Year ending September 30, 2018 258,300 2019 475,761 2020 445,092 2021 248,667 2022 118,410 Total $ 1,546,230

SUBSEQUENT EVENTS

SUBSEQUENT EVENTS	6 Months Ended
	Mar. 31, 2018
Notes to Financial Statements
NOTE 14 - SUBSEQUENT EVENTS	Employment Agreements On April 16, 2018, the Company entered into an employment agreement with our Chief Financial Officer which carries a two-year term with a base salary of $150,000 annually plus incentive based bonuses of $20,000. Additionally, the Company granted 200,000 shares of common stock and 150,000 stock options exercisable at $1.28 per share which vest in equal quarterly installments over the term of the agreement. Common Stock Issuances The Company made the following issuances of common stock subsequent to March 31, 2018: · 992,265 common shares for the conversion of $677,885 of outstanding principal on convertible notes payable. All conversions were performed at contractual terms. · 66,133 common shares for the conversion of $45,135 of outstanding interest on convertible notes payable. All conversions were performed at contractual terms. · 15,000 common shares valued at $18,750 subject to the vesting requirements of certain agreements with consultants. · 125,000 common shares valued at $157,000 subject to the vesting requirements of certain agreements with employees. Entries into Material Agreements On April 29, 2018, EVIO Labs Humbolt, Inc. (“EVIO Humbolt”), a wholly-owned subsidiary of the Company entered into an Asset Purchase Agreement with Leaf Detective, LLC. (“Leaf Detective”). Pursuant to the Agreement, Leaf Detective agreed to sell its assets including equipment, tools, brand, customer lists, customer contracts, rental agreements, and equipment leases for total consideration of $500,000 in a Convertible Promissory Note (“Note”). The Note is convertible at $1.25 per share, bears no interest and has a maturity of 12 months from the closing of the agreement. The agreement otherwise contains standard representations and warranties. On May 2, 2018, EVIO Canada, Inc, (“EVIO Canada”), a wholly-owned subsidiary of the Company consummated Stock Purchase Agreements to acquire a 50% interest of Keystone Labs, Inc. (“Keystone”). Keystone agreed to sell, assign and transfer to EVIO Canada and EVIO Canada agreed to purchase certain amounts of Class A shares and Class B shares of Keystone representing 50% of the issued and outstanding shares in the capital of Keystone for CAD $2,495,000. Furthermore, the Company agreed to advance Keystone an amount up to CAD $1,000,000. For the value received under the credit agreement, the Company received a promissory note with an 8% per annum interest rate on all outstanding sums. In connection with EVIO’s purchase of 50% of Keystone, the shareholders of Keystone subscribed for an aggregate of 1,291,391 of common shares in the capital of EVIO for an aggregate purchase price of CAD $1,950,000 on a private placement basis.

SUMMARY OF SIGNIFICANT ACCOUN20

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)	6 Months Ended
	Mar. 31, 2018
Summary Of Significant Accounting Policies Policies
Basis of Presentation	The accompanying unaudited interim consolidated financial statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States of America and the rules of the Securities and Exchange Commission, and should be read in conjunction with the audited consolidated financial statements and notes thereto contained in the Company’s most recent Annual Financial Statements filed with the SEC on Form 10-K. In the opinion of management, all adjustments, consisting of normal recurring adjustments, necessary for a fair presentation of financial position and the results of operations for the interim period presented have been reflected herein. The results of operations for the interim period are not necessarily indicative of the results to be expected for the full year. Notes to the financial statements which would substantially duplicate the disclosures contained in the audited consolidated financial statements for the most recent fiscal period, as reported in the Form 10-K, have been omitted.
Principles of Consolidation	The Company prepares its financial statements on the accrual basis of accounting. The accompanying consolidated financial statements include the accounts of the Company and its wholly and partially owned subsidiaries, all of which have a fiscal year end of September 30. All intercompany accounts, balances and transactions have been eliminated in the consolidation. The Company consolidates its subsidiaries in accordance with ASC 810, and specifically ASC 810-10-15-8 which states, the usual condition for a controlling financial interest is ownership of a majority voting interest, and, therefore, as a general rule ownership by one reporting entity, directly or indirectly, or over 50% of the outstanding voting shares of another entity is a condition pointing toward consolidation.
Use of Estimates	The preparation of financial statements in accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. A change in managements’ estimates or assumptions could have a material impact on the Company’s financial condition and results of operations during the period in which such changes occurred. Actual results could differ from those estimates. The Company’s financial statements reflect all adjustments that management believes are necessary for the fair presentation of their financial condition and results of operations for the periods presented.
Financial Instruments	Level 1 - applies to assets or liabilities for which there are quoted prices in active markets for identical assets or liabilities. Level 2 - applies to assets or liabilities for which there are inputs other than quoted prices that are observable for the asset or liability such as quoted prices for similar assets or liabilities in active markets; quoted prices for identical assets or liabilities in markets with insufficient volume or infrequent transactions (less active markets); or model-derived valuations in which significant inputs are observable or can be derived principally from, or corroborated by, observable market data. Level 3 - applies to assets or liabilities for which there are unobservable inputs to the valuation methodology that are significant to the measurement of the fair value of the assets or liabilities. The Company's financial instruments consist principally of cash, accounts payable, and accrued liabilities. Pursuant to ASC 820 and 825, the fair value of cash is determined based on "Level 1" inputs, which consist of quoted prices in active markets for identical assets. The recorded values of all other financial instruments approximate their current fair values because of their nature and respective maturity dates or durations. The following table sets forth by level with the fair value hierarchy the Company's financial assets and liabilities measured at fair value on March 31, 2018: Level 1 Level 2 Level 3 Total Liabilities Derivative financial instruments $ - $ - $ 3,123,223 $ 3,123,223 The following table sets forth by level with the fair value hierarchy the Company's financial assets and liabilities measured at fair value on September 30, 2017: Level 1 Level 2 Level 3 Total Liabilities Derivative financial instruments $ - $ - $ 294,637 $ 294,637
Recently Issued Accounting Pronouncements	In January 2017, the FASB issued ASU 2017-04, “ Intangibles—Goodwill and Other (Topic 350), Simplifying the Test for Goodwill Impairment”. In January 2017, the FASB issued ASU 2017-01, “ Business Combinations (Topic 805): Clarifying the Definition of a Business, In April 2016, the FASB issued ASU 2016-10, "Revenue from Contracts with Customers (Topic 606): Identifying Performance Obligations and Licensing" ("ASU 2016-1O"). The amendments in this update clarify the following two aspects to Topic 606: identifying performance obligations and the licensing implementation guidance, while retaining the related principles for those areas. The entity first identifies the promised goods or services in the contract and reduces the cost and complexity. An entity evaluates whether promised goods and services are distinct. Topic 606 includes implementation guidance on determining whether an entity's promise to grant a license provides a customer with either a right to use the entity's intellectual property (which is satisfied at a point in time) or a right to access the entity's intellectual property (which is satisfied over time). The Company evaluated the impacts of ASU 2016-10 and does not believe it will an impact on the Company’s revenue recognition practices and will adopt the standard on October 1, 2018. Other accounting standards that have been issued or proposed by the FASB or other standards-setting bodies that do not require adoption until a future date are not expected to have a material impact on our financial statements upon adoption.
Net Income (Loss) Per Share	Basic loss per share is computed by dividing net income, or loss, by the weighted average number of shares of common stock outstanding for the period. Diluted earnings (loss) per share is computed by dividing net income, or loss, by the weighted average number of shares of common stock outstanding for the period. There were 13,688,531 and 9,958,808 potentially dilutive common shares outstanding as of March 31, 2018 and 2017. Because of the net losses incurred during the three and six months ended March 31, 2018 and 2017, the impacts of dilutive instruments would have been anti-dilutive for the period presented and have been excluded from the diluted loss per share calculations.
Accounts Receivable and Allowance for Doubtful Accounts	Accounts receivable are recorded at their original invoice amounts. We regularly review collectability and establish an allowance for uncollectible amounts as necessary based on our experience with historical collectability. There was an allowance for uncollectible accounts receivable of $77,850 and $74,782 as of March 31, 2018 and September 30, 2017, respectively.
Notes Receivable	The Company accounts investments for notes receivable in accordance with ASC 320. On September 6, 2017, the Company entered in a note receivable with an unrelated entity for $1,300,000. During the six months ended March 31, 2018, the Company made additional advances of $39,987. The note is due on September 6, 2024 and carries interest at a rate of 8% per annum. The note requires minimum principal payments of $100,000 plus accrued interest on each anniversary date with the unpaid principal and interest being due on September 6, 2024. The Company evaluated the collectability of the note receivable as of March 31, 2018 and September 30, 2017 and determined the full balance is collectible and no reserve for write off was recorded. As of March 31, 2018 and September 30, 2017, there was $1,339,987 of principal, of which $100,000 was current and $1,239,987 was long term. Additionally, there was $59,485 and $6,838 of interest due as of March 31, 2018 and September 30, 2017 which is included in other current assets.
Goodwill and Other Intangible Assets	Goodwill and indefinite-lived intangible assets are not amortized but are evaluated for impairment annually or more often if indicators of a potential impairment are present. Our annual impairment tests are conducted at the beginning of the fourth quarter. We use a two-step process to quantitatively evaluate goodwill for impairment. In the first step, we compare the fair value of each reporting unit with the carrying amount of the reporting unit, including goodwill. If the estimated fair value of the reporting unit is less than the carrying amount of the reporting unit, we complete a second step to determine the amount of the goodwill impairment that we should record. In the second step, we determine an implied fair value of the reporting unit's goodwill by allocating the reporting unit's fair value to all of its assets and liabilities other than goodwill (including any unrecognized intangible assets). We compare the resulting implied fair value of the goodwill to the carrying amount and record an impairment charge for the difference. We test individual indefinite-lived intangible assets by comparing the estimated fair value with the book values of each asset. The Company recognizes an acquired intangible apart from goodwill whenever the intangible arises from contractual or other legal rights, or whenever it can be separated or divided from the acquired entity and sold, transferred, licensed, rented or exchanged, either individually or in combination with a related contract, asset or liability. Such intangibles are amortized on a straight-line basis over their estimated useful lives unless the estimated useful life is determined to be indefinite. The Company’s intangible assets consist of client lists (amortized over five years), websites, non-compete agreements (amortized over 5 years), domain names (amortized over 15 years) and testing licenses (amortized over 5 years).
Stock-Based Compensation	The Company applies Topic 718 “Share-Based Payments” (“Topic 718”) to share-based compensation, which requires the measurement of the cost of services received in exchange for an award of an equity instrument based on the grant-date fair value of the award. Compensation cost is recognized when the event occurs. The Black-Scholes option-pricing model is used to estimate the fair value of options granted. The Company accounts for equity-based transactions with non-employees under the provisions of ASC Topic No. 505-50, “Equity-Based Payments to Non-Employees” (“Topic No. 505-50”). Topic No. 505-50 establishes that equity-based payment transactions with non-employees shall be measured at the fair value of the consideration received or the fair value of the equity instruments issued, whichever is more reliably measurable.
Non-Controlling Interest	The Company reports the non-controlling interest in its majority owned subsidiaries in the consolidated balance sheets within the stockholders’ deficit section, separately from the Company’s stockholders’ deficit. Non-controlling interest represents the non-controlling interest holders’ proportionate share of the equity of the Company’s majority-owned subsidiaries. Non-controlling interest is adjusted for the non-controlling interest holders’ proportionate share of the earnings or losses and other comprehensive income (loss) and the non-controlling interest continues to be attributed its share of losses even if that attribution results in a deficit non-controlling interest balance.
Related Parties	The registrant follows subtopic 850-10 of the FASB Accounting Standards Codification for the identification of related parties and disclosure of related party transactions. Pursuant to Section 850-10-20 the Related parties include (a) affiliates of the registrant; (b) entities for which investments in their equity securities would be required, absent the election of the fair value option under the Fair Value Option Subsection of Section 825–10–15, to be accounted for by the equity method by the investing entity; (c) trusts for the benefit of employees, such as pension and profit-sharing trusts that are managed by or under the trusteeship of management; (d) principal owners of the registrant; (e) management of the registrant; (f) other parties with which the registrant may deal if one party controls or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests; and (g) Other parties that can significantly influence the management or operating policies of the transacting parties or that have an ownership interest in one of the transacting parties and can significantly influence the other to an extent that one or more of the transacting parties might be prevented from fully pursuing its own separate interests. The financial statements shall include disclosures of material related party transactions, other than compensation arrangements, expense allowances, and other similar items in the ordinary course of business. However, disclosure of transactions that are eliminated in the preparation of consolidated or combined financial statements is not required in those statements. The disclosures shall include: (a) the nature of the relationship(s) involved; (b) description of the transactions, including transactions to which no amounts or nominal amounts were ascribed, for each of the periods for which income statements are presented, and such other information deemed necessary to an understanding of the effects of the transactions on the financial statements; (c) the dollar amounts of transactions for each of the periods for which income statements are presented and the effects of any change in the method of establishing the terms from that used in the preceding period; and (d) amounts due from or to related parties as of the date of each balance sheet presented and, if not otherwise apparent, the terms and manner of settlement.
Capital Leases	The Company accounts for capital leases in accordance with ACS 840-30. During the year ended September 30, 2017, the Company entered into three separate long-term leases for equipment that contain a $1 buyout option upon lease termination. The Company determined these were capital leases based on the minimum buy out price and capitalized the net present value of the leases which totaled $116,800 as equipment. On February 2, 2018, the Company entered into a long term lease for equipment that contain a bargain purchase option upon lease termination. The Company determined this was a capital lease based on the minimum buy out price and capitalized the net present value of the lease of $385,208 plus the required up front cash payment of $39,986 which totaled $425,194 as equipment. As of September 30, 2017, there was a total of $111,501 of future payments due through December 2019 of which $20,734 are financing charges leaving a total principal balance of $90,967 as of September 30, 2017. Of this amount, $37,990 was current and $52,777 was long term as of September 30, 2017. As of March 31, 2018, there was a total of $499,242 of future payments due through March 2021 of which $45,614 are financing charges leaving a total principal balance of $453,628 as of March 31, 2018. Of this amount, $140,184 was current and $313,444 was long term as of March 31, 2018. Future annual payments required under the capital leases through termination are as follows: Year ended September 30, Principal Interest Total 2018 $ 69,198 $ 14,390 $ 83,588 2019 144,889 19,671 164,560 2020 121,904 9,210 131,114 2021 117,637 2,343 119,980 Total $ 453,628 $ 45,614 $ 499,242
Concentration of Credit Risk	Instruments that potentially subject the Company to concentration of credit risk consist principally of cash deposits, notes receivable and accounts receivable. As of March 31, 2018 and September 30, 2017, the Company held $2,472,536 and $0 of cash at one financial institution in excess of the amount insured by the Federal Deposit Insurance Corporation (“FDIC”) of up to $250,000. As of March 31, 2018 and September 30, 2017, the Company had a note receivable totaling $1,339,987 and $1,300,000 due from a single entity. As of September 30, 2017, the Company had total accounts receivable net of allowances of $229,564. Three separate clients comprised a total of 41% of this balance as follows: Balance Percent of Total Customer 1 $ 42,878 14 % Customer 2 45,635 15 % Customer 3 37,540 12 % All others 178,294 59 % Total 304,347 100 % Allowance for doubtful accounts (74,783 ) Net accounts receivable $ 229,564 As of March 31, 2018 the Company had total accounts receivable net of allowances of $215,540. Three separate clients comprised a total of 35% of this balance as follows: Balance Percent of Total Customer 1 $ 33,219 11 % Customer 2 45,635 16 % Customer 3 36,600 12 % All others 177,936 61 % Total 293,390 Allowance for doubtful accounts (77,850 ) Net accounts receivable $ 215,540
Property and Equipment	Property and equipment are carried at cost. Expenditures for maintenance and repairs are expensed in the period incurred. Renewals and betterments that materially extend the life of the assets are capitalized. When assets are retired or otherwise disposed of, the cost and related accumulated depreciation are removed from the accounts, and any resulting gain or loss is reflected in income for the period. Depreciation is computed for financial statement purposes on a straight-line basis over estimated useful lives of the related assets and the modified accelerated cost recovery system for federal income tax purposes. The estimated useful lives of depreciable assets are: Estimated Useful Lives Laboratory and Computer Equipment 5 years Furniture and Fixtures 7 years Software 3 years Domains 15 years The Company’s property and equipment consisted of the following as of March 31, 2018 and September 30, 2017: March 31, 2018 September 30, 2017 Furniture and Equipment $ 169,051 $ 146,870 Laboratory Equipment 1,543,487 439,071 Software 58,333 58,333 Leasehold Improvements 107,318 41,081 Vehicles 83,915 75,165 Total 1,962,104 760,520 Accumulated depreciation (345,308 ) (213,447 ) Net value $ 1,616,796 $ 547,073 The Company capitalized a total of $425,194 of equipment purchased through capital leases and recorded depreciation expense of $23,619 and $6,029 and $33,064 and $8,134 and on that equipment during the three and six months ended March 31, 2018 and 2017, respectively.

SUMMARY OF SIGNIFICANT ACCOUN21

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)	6 Months Ended
	Mar. 31, 2018
Summary Of Significant Accounting Policies Tables
Financial assets and liabilities measured at fair value	The following table sets forth by level with the fair value hierarchy the Company's financial assets and liabilities measured at fair value on March 31, 2018: Level 1 Level 2 Level 3 Total Liabilities Derivative financial instruments $ - $ - $ 3,123,223 $ 3,123,223 The following table sets forth by level with the fair value hierarchy the Company's financial assets and liabilities measured at fair value on September 30, 2017: Level 1 Level 2 Level 3 Total Liabilities Derivative financial instruments $ - $ - $ 294,637 $ 294,637
Future annual payments capital lease	Future annual payments required under the capital leases through termination are as follows: Year ended September 30, Principal Interest Total 2018 $ 69,198 $ 14,390 $ 83,588 2019 144,889 19,671 164,560 2020 121,904 9,210 131,114 2021 117,637 2,343 119,980 Total $ 453,628 $ 45,614 $ 499,242
Concentration of Credit Risk	As of September 30, 2017, the Company had total accounts receivable net of allowances of $229,564. Three separate clients comprised a total of 41% of this balance as follows: Balance Percent of Total Customer 1 $ 42,878 14 % Customer 2 45,635 15 % Customer 3 37,540 12 % All others 178,294 59 % Total 304,347 100 % Allowance for doubtful accounts (74,783 ) Net accounts receivable $ 229,564 As of March 31, 2018 the Company had total accounts receivable net of allowances of $215,540. Three separate clients comprised a total of 35% of this balance as follows: Balance Percent of Total Customer 1 $ 33,219 11 % Customer 2 45,635 16 % Customer 3 36,600 12 % All others 177,936 61 % Total 293,390 Allowance for doubtful accounts (77,850 ) Net accounts receivable $ 215,540
Estimated useful lives of depreciable assets	Estimated Useful Lives Laboratory and Computer Equipment 5 years Furniture and Fixtures 7 years Software 3 years Domains 15 years
Plant and Equipment	March 31, 2018 September 30, 2017 Furniture and Equipment $ 169,051 $ 146,870 Laboratory Equipment 1,543,487 439,071 Software 58,333 58,333 Leasehold Improvements 107,318 41,081 Vehicles 83,915 75,165 Total 1,962,104 760,520 Accumulated depreciation (345,308 ) (213,447 ) Net value $ 1,616,796 $ 547,073

INTANGIBLE ASSETS (Tables)

INTANGIBLE ASSETS (Tables)	6 Months Ended
	Mar. 31, 2018
Intangible Assets Tables
Schedule of impaired intangible assets	March 31, 2018 September 30, 2017 Customer list $ 592,670 $ 480,670 License 503,000 256,000 Favorable lease 3,100 3,100 Website 41,965 41,965 Non-compete agreement 88,000 - Total 1,228,735 781,735 Accumulated amortization (283,589 ) (189,475 ) Net value $ 945,146 $ 592,260
Schedule of future amortization associated with the intangible assets acquired	For the years ended September 30, Amortization 2018 $ 109,268 2019 218,537 2020 218,537 2021 176,362 2022 78,607 Thereafter 143,835 Total $ 945,146

LOANS PAYABLE (Tables)

LOANS PAYABLE (Tables)	6 Months Ended
	Mar. 31, 2018
Loans Payable Tables
Schedule of loans payable outstanding	The Company had the following loans payable outstanding as of March 31, 2018 and September 30, 2017: March 31, 2018 September 30, 2017 On March 16, 2017, the Company executed notes payable for the purchase of three vehicles. The notes carry interest at 6.637% annually and mature on March 31, 2023. $ 65,691 $ 71,039 On August 1, 2017, the Company entered into a note payable totaling $500,000 for the acquisition of Viridis (see note 3). The note carries interest at 8% annually and is due on July 1, 2018. 500,000 500,000 On September 6, 2017, the Company entered into a note payable totaling $1,000,000 for the purchase of an outstanding note receivable. The note carries interest at 8% annually and is due on July 6, 2018. 500,000 1,000,000 On August 31, 2017, the Company executed a note payable for $120,000 of which $20,000 was an original issue discount resulting in cash proceeds of $100,000. The note carries interest at 8% annually and is due on March 3, 2018. - 120,000 1,065,691 1,691,039 Less: unamortized original issue discounts (37,024 ) (127,662 ) Total loans payable 1,028,667 1,563,377 Less: current portion of loans payable 975,192 1,503,545 Long-term portion of loans payable $ 53,475 $ 59,832

CONVERTIBLE NOTES PAYABLE (Tabl

CONVERTIBLE NOTES PAYABLE (Tables)	6 Months Ended
	Mar. 31, 2018
Convertible Notes Payable Tables
Schedule of convertible notes payable outstanding	The following table summarizes all convertible notes outstanding as of September 30, 2017: Holder Issue Date Due Date Principal Unamortized Debt Discount Carrying Value Accrued Interest Noteholder 1 3/2/2017 3/2/2018 $ 125,000 $ (38,112 ) $ 86,888 $ 5,671 Noteholder 1 7/14/2017 7/14/2018 275,600 (11,795 ) 263,805 4,712 Noteholder 1 8/14/2017 8/14/2018 275,600 (13,068 ) 262,532 2,839 Noteholder 4 3/2/2017 3/2/2018 69,000 (50,009 ) 18,991 7,187 Noteholder 4 6/5/2017 3/2/2018 125,000 (70,833 ) 54,167 3,205 Noteholder 4 7/14/2017 7/14/2018 275,600 (11,795 ) 263,805 4,470 Noteholder 4 8/14/2017 8/14/2018 275,600 (13,068 ) 262,532 2,597 $ 1,421,400 $ (208,680 ) $ 1,212,720 $ 30,681 The following table summarizes all convertible notes outstanding as of March 31, 2018: Holder Issue Date Due Date Principal Unamortized Debt Discount Carrying Value Accrued Interest Noteholder 1 7/14/2017 7/14/2018 $ 40,300 $ (26,071 ) $ 14,229 $ 6,297 Noteholder 1 8/14/2017 8/14/2018 275,600 (200,290 ) 75,310 13,815 Noteholder 4 7/14/2017 7/14/2018 126,685 (73,348 ) 53,337 15,683 Noteholder 4 8/14/2017 8/14/2018 275,600 (200,289 ) 75,311 13,815 Noteholder 5 1/1/2018 6/30/2018 500,000 - 500,000 - $ 1,218,185 $ (499,998 ) $ 718,187 $ 49,610

CONVERTIBLE DEBENTURES (Tables)

CONVERTIBLE DEBENTURES (Tables)	6 Months Ended
	Mar. 31, 2018
Debt Issuance Costs [Member]
Schedule of warrants assumptions table	The warrants associated with the debt issue costs were valued using a Black-Scholes model with the following assumptions: Expected term of options granted 2.00 years Expected volatility 223 % Risk-free interest rate 2.49 % Expected dividend yield 0 %
Convertible debt [Member]
Schedule of warrants assumptions table	The Company separately valued the detachable warrants issued with the convertible debentures at $3,351,160 using a Black-Scholes model with the following assumptions: Expected term of options granted 2.00 years Expected volatility 211-223 % Risk-free interest rate 2.09-2.25 % Expected dividend yield 0 %

DERIVATIVE LIABILITIES (Tables)

DERIVATIVE LIABILITIES (Tables)	6 Months Ended
	Mar. 31, 2018
Derivative Liabilities Tables
Summary of derivative liabilities	The following table summarizes the derivative liabilities included in the balance sheet at September 30, 2017: Fair Value of Embedded Derivative Liabilities: Balance, September 30, 2016 $ 775,246 Initial measurement of derivative liabilities 1,312,384 Change in fair market value (195,907 Write off due to conversion (1,597,086 ) Balance, September 30, 2017 $ 294,637 The following table summarizes the derivative liabilities included in the balance sheet at March 31, 2018: Fair Value of Embedded Derivative Liabilities: Balance, September 30, 2017 $ 294,637 Initial measurement of derivative liabilities 6,115,697 Change in fair market value (2,404,657 ) Write off due to conversion (882,454 ) Balance, March 31, 2018 $ 3,123,223
Summary of loss on derivative liability	Three Months Ended March 31, Six Months Ended March 31, 2018 2017 2018 2017 Day one loss due to derivatives on convertible debt $ (610,566 ) $ (64,492 ) $ (610,566 ) $ (352,206 ) Change in fair value of derivatives 2,391,335 (20,543 ) 2,404,657 160,928 Total derivative expense (gain) $ 1,780,769 $ (85,035 ) $ 1,794,091 $ (191,278 )

ACQUISITIONS (Tables)

ACQUISITIONS (Tables)	6 Months Ended
	Mar. 31, 2018
Acquisitions Tables
Schedule of Assets Acquired and Liabilities Assumed	ASSETS ACQUIRED Cash $ 20,468 Accounts receivable 5,110 Other current assets 3,461 Security deposits 20,000 Equipment 244,875 License 247,000 Customer list 112,000 Non-compete agreement 88,000 Goodwill 291,697 TOTAL ASSETS ACQUIRED $ 1,032,611 LIABILITIES ASSUMED Accounts payable 4,314 Deferred rent 28,297 TOTAL LIABILITIES ASSUMED 32,611 Non-controlling interest (400,000 ) NET ASSETS ACQUIRED $ 600,000

INDUSTRY SEGMENTS (Tables)

INDUSTRY SEGMENTS (Tables)	6 Months Ended
	Mar. 31, 2018
Industry Segments Tables
Summary of the Company's current segments	Six months ended March 31, 2018 Corporate Consulting Services Testing Services Total Consolidated Revenue $ - $ 102,816 $ 1,576,360 $ 1,679,176 Segment income (loss) from operations (1,459,932 ) (975,276 ) (594,792 ) (3,030,000 ) Total assets 4,262,523 217,092 6,828,299 11,307,914 Capital expenditures - (1,038 ) (530,476 ) (531,514 ) Depreciation and amortization - 7,171 218,804 225,975 Six months ended March 31, 2017 Corporate Consulting Services Testing Services Total Consolidated Revenue $ - $ 187,175 $ 1,314,004 $ 1,501,179 Segment income (loss) from operations (378,704 ) 4,648 (299,118 ) (673,174 ) Total assets 93,328 90,600 3,811,833 3,995,761 Capital expenditures - (1,038 ) (44,726 ) (45,764 ) Depreciation and amortization - 11,947 108,783 120,730 Three months ended March 31, 2018 Corporate Consulting Services Testing Services Total Consolidated Revenue $ - $ 43,300 $ 689,011 $ 732,311 Segment income (loss) from operations (1,264,646 ) (618,691 ) (479,603 ) (2,362,940 ) Total assets 4,262,523 217,092 6,828,299 11,307,914 Capital expenditures - - (524,562 ) (524,562 ) Depreciation and amortization - 1,197 138,278 139,475 Three months ended March 31, 2017 Corporate Consulting Services Testing Services Total Consolidated Revenue $ - $ 87,297 $ 745,426 $ 832,723 Segment income (loss) from operations (163,362 ) (7,717 ) (110,779 ) (281,858 ) Total assets 93,328 90,600 3,811,833 3,995,761 Capital expenditures - - (19,450 ) (19,450 ) Depreciation and amortization - 5,973 61,920 67,893

STOCK OPTIONS AND WARRANTS (Tab

STOCK OPTIONS AND WARRANTS (Tables)	6 Months Ended
	Mar. 31, 2018
Stock Options And Warrants Tables
Summary of stock option and warrant activity	The following table summarizes all stock option and warrant activity for the year ended September 30, 2017 and the six months ended March 31, 2018: Shares Weighted- Average Exercise Price Per Share Outstanding, September 30, 2016 315,000 $ 0.449 Granted 380,000 1.295 Exercised - - Forfeited (40,000 ) 1.075 Expired - - Outstanding, September 30, 2017 655,000 $ 0.902 Shares Weighted- Average Exercise Price Per Share Outstanding, September 30, 2017 655,000 $ 0.902 Granted 3,948,050 0.763 Exercised - - Forfeited (70,000 ) 0.891 Expired - - Outstanding, March 31, 2018 4,533,050 $ 0.781
Schedule of outstanding and exercisable options and warrants	The following table discloses information regarding outstanding and exercisable options and warrants at September 30, 2017: Outstanding Exercisable Exercise Prices Number of Option Shares Weighted Average Exercise Price Weighted Average Remaining Life (Years) Number of Option Shares Weighted Average Exercise Price $ 0.400 150,000 $ 0.400 3.88 75,000 $ 0.400 $ 0.500 155,000 $ 0.500 3.88 77,500 $ 0.500 $ 1.260 270,000 $ 1.260 4.75 - $ 1.260 $ 1.386 60,000 $ 1.386 4.75 - $ 1.386 $ 1.300 10,000 $ 1.300 4.05 2,500 $ 1.300 $ 1.666 10,000 $ 1.666 4.84 - 1.666 Total 655,000 $ 0.902 4.33 155,000 $ 0.465 The following table discloses information regarding outstanding and exercisable options and warrants at March 31, 2018: Outstanding Exercisable Exercise Prices Number of Option Shares Weighted Average Exercise Price Weighted Average Remaining Life (Years) Number of Option Shares Weighted Average Exercise Price $ 0.400 120,000 $ 0.400 3.38 90,000 $ 0.400 $ 0.500 165,000 $ 0.500 3.45 121,250 $ 0.500 $ 0.600 597,300 $ 0.600 1.83 597,300 $ 0.600 $ 0.650 145,000 $ 0.650 4.57 - $ 0.650 $ 0.800 3,195,750 $ 0.800 3.24 2,420,750 $ 0.800 $ 1.260 230,000 $ 1.260 4.25 57,500 $ 1.260 $ 1.300 10,000 $ 1.300 3.56 5,000 $ 1.300 $ 1.386 60,000 $ 1.386 4.25 15,000 $ 1.386 $ 1.666 10,000 $ 1.666 4.34 2,500 $ 1.666 Total 4,533,050 $ 0.781 3.82 3,309,300 $ 0.754
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions	September 30, 2017 Expected term of options granted 5 years Expected volatility 2.68 % Risk-free interest rate 1.89 % Expected dividend yield 0 % March 31, 2018 Expected term of options granted 4.98 – 5.00 years Expected volatility 251-256 % Risk-free interest rate 2.01–2.25 % Expected dividend yield 0 %

COMMETTMENTS AND CONTINGECIES (

COMMETTMENTS AND CONTINGECIES (Tables)	6 Months Ended
	Mar. 31, 2018
Commettments And Contingecies Tables
Operating Leases	Year ending September 30, 2018 258,300 2019 475,761 2020 445,092 2021 248,667 2022 118,410 Total $ 1,546,230

NATURE OF ACTIVITIES AND CONT31

NATURE OF ACTIVITIES AND CONTINUANCE OF BUSINESS (Details Narrative) - Purchase Agreement [Member]	Jun. 01, 2016	Mar. 31, 2018	Dec. 29, 2017	Oct. 19, 2016	Sep. 17, 2015
Mr. Waldrop and Ms. Glauser [Member]
Common stock purchase		80.00%
C3 Labs [Member]
Acquired shares percentage			60.00%
Smith Scientific Industries [Member]
Common stock purchase	80.00%
Greenhaus Analytical Labs, LLC [Member]
Ownership percentage				100.00%
CR Labs [Member]
Acquired shares percentage					80.00%

SUMMARY OF SIGNIFICANT ACCOUN32

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) - USD ($)	Mar. 31, 2018	Sep. 30, 2017
Liabilities
Derivative financial instruments	$ 3,123,223	$ 294,637
Level 1 [Member]
Liabilities
Derivative financial instruments
Level 2 [Member]
Liabilities
Derivative financial instruments
Level 3 [Member]
Liabilities
Derivative financial instruments	$ 3,123,223	$ 294,637

SUMMARY OF SIGNIFICANT ACCOUN33

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details 1)	Mar. 31, 2018USD ($)
2,018	$ 83,588
2,019	164,560
2,020	131,114
2,021	119,980
Total	499,242
Interest [Member]
2,018	14,390
2,019	19,671
2,020	9,210
2,021	2,343
Total	45,614
Principal [Member]
2,018	69,198
2,019	144,889
2,020	121,904
2,021	117,637
Total	$ 453,628

SUMMARY OF SIGNIFICANT ACCOUN34

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details 2) - USD ($)	6 Months Ended	12 Months Ended
	Mar. 31, 2018	Sep. 30, 2017
Total	$ 293,390	$ 304,347
Allowance for doubtful accounts	(77,850)	(74,783)
Net accounts receivable	$ 215,540	$ 229,564
Concentration of Credit Risk percentage		100.00%
Customer 1 [Member]
Total	$ 33,219	$ 42,878
Concentration of Credit Risk percentage	11.00%	14.00%
Customer 2 [Member]
Total	$ 45,635	$ 45,635
Concentration of Credit Risk percentage	16.00%	15.00%
Customer 3 [Member]
Total	$ 36,600	$ 37,540
Concentration of Credit Risk percentage	12.00%	12.00%
All others [Member]
Total	$ 177,936	$ 178,294
Concentration of Credit Risk percentage	61.00%	59.00%

SUMMARY OF SIGNIFICANT ACCOUN35

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details 3)	6 Months Ended
	Mar. 31, 2018
Laboratory and Computer Equipment [Member]
Estimated useful life	5 years
Furniture and Fixtures [Member]
Estimated useful life	7 years
Software [Member]
Estimated useful life	3 years
Domains [Member]
Estimated useful life	15 years

SUMMARY OF SIGNIFICANT ACCOUN36

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details 4) - USD ($)	Mar. 31, 2018	Sep. 30, 2017
Total	$ 1,962,104	$ 760,520
Accumulated depreciation	(345,308)	(213,447)
Net value	1,616,796	547,073
Furniture and Equipment [Member]
Total	169,051	146,870
Laboratory Equipment [Member]
Total	1,543,487	439,071
Software [Member]
Total	58,333	58,333
Leasehold Improvements [Member]
Total	107,318	41,081
Vehicles [Member]
Total	$ 83,915	$ 75,165

SUMMARY OF SIGNIFICANT ACCOUN37

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - USD ($)	Feb. 02, 2018	Mar. 31, 2018	Mar. 31, 2017	Mar. 31, 2018	Mar. 31, 2017	Sep. 30, 2017	Sep. 06, 2017
Voting equity interests		50.00%		50.00%
Potentially dilutive common shares outstanding				13,688,531	9,958,808
Accounts receivable, net of allowance		$ 77,850		$ 77,850		$ 74,782
Note receivable current		100,000		100,000		100,000
Note receivable		1,339,987		1,339,987		1,300,000	$ 1,300,000
Note receivable additional advances				39,987
Note receivable long term		1,239,987		$ 1,239,987		1,200,000
Due date				Sep. 6, 2024
Interest rate				8.00%
Interest amount				$ 59,485		6,838
Capital lease obligation, current		140,184		140,184		37,990
Accounts receivable, net of allowance		215,540		215,540		229,564
Capital lease obligation, non current portion		313,444		313,444		52,777
Net present value of leased equipment	$ 425,194	425,194		425,194		116,800
Net present value of leased equipment, Description	The Company determined this was a capital lease based on the minimum buy out price and capitalized the net present value of the lease of $385,208 plus the required up front cash payment of $39,986 which totaled $425,194 as equipment.
Capital lease future payment		499,242		$ 499,242		$ 111,501
Future payment due date				March 2,021		December 2,019
Financing charges		45,614		$ 45,614		$ 20,734
Total principal balance		453,628		453,628		90,967
Cash, FDIC Insured Amount		250,000		250,000		250,000
Minimum principal payment		100,000		100,000
Depreciation expense		23,619	$ 6,029	$ 33,064	$ 8,134
Lease termination description				the Company entered into three separate long-term leases for equipment that contain a $1 buyout option upon lease termination.
Cash held in excess of FDIC limit		$ 2,472,536		$ 2,472,536		$ 0
Client lists [Member]
Amortization of Intangible Assets				5 years
Websites and Domain Names [Member]
Amortization of Intangible Assets				15 years
Testing Licenses [Member]
Amortization of Intangible Assets				5 years

INTANGIBLE ASSETS (Details)

INTANGIBLE ASSETS (Details) - USD ($)	Mar. 31, 2018	Sep. 30, 2017
Total	$ 1,228,735	$ 781,735
Accumulated amortization	(283,589)	(189,475)
Net value	945,146	592,260
Customer Lists [Member]
Total	592,670	480,670
License [Member]
Total	503,000	256,000
Favorable lease [Member]
Total	3,100	3,100
Website [Member]
Total	41,965	41,965
Non-compete agreement [Member]
Total	$ 88,000

INTANGIBLE ASSETS (Details 1)

INTANGIBLE ASSETS (Details 1) - USD ($)	Mar. 31, 2018	Sep. 30, 2017
Total	$ 945,146	$ 592,260
Amortization [Member]
2,018	109,268
2,019	218,537
2,020	218,537
2,021	176,362
2,022	78,607
Thereafter	143,835
Total	$ 945,146

RELATED PARTY TRANSACTIONS (Det

RELATED PARTY TRANSACTIONS (Details Narrative) - USD ($)	Mar. 05, 2018	Sep. 06, 2017	Nov. 01, 2016	Jun. 01, 2016	Aug. 31, 2017	Oct. 19, 2016	May 24, 2016	Mar. 31, 2018	Mar. 31, 2017	Mar. 31, 2018	Mar. 31, 2017	Sep. 30, 2017	Sep. 30, 2016
Proceeds from notes payable - related party											$ 80,100
Repayment to related party										14,000		$ 22,050
Notes Payable - Related Party, less Current Portion								$ 1,190,428		1,190,428		1,251,306
Unamortized Debt discount					$ 20,000			(499,998)		(499,998)		(208,680)
Maturity date		Jul. 6, 2018			Mar. 3, 2018
Principal balance								$ 453,628		$ 453,628		$ 90,967
Common stock shares issue								16,068,505		16,068,505		10,732,922
Common Stock, value								$ 1,607		$ 1,607		$ 1,073
Losses on extinguishment of debt										(56,093)
Relate party Agreement [Member]
Due to related parties								200,000		200,000
Interest rate	8.00%
Current Portion - Notes Payable - Related Party	$ 200,000
Maturity date	Mar. 5, 2021
Description of common stock discretion	Common stock of the issuer at the Company’s discretion at $0.03 per share.
Chief Science Officer [Member]
Borrowed amount													$ 16,200
Due to related parties								0		0		9,200
Repayment to related party										9,200		7,000
Green Style Consulting, LLC [Member]
Company repaid										21,328		6,090
Due to related parties								22,582		22,582		43,910
Interest rate			5.00%
Current Portion - Notes Payable - Related Party			$ 50,000
Unamortized note premium								3,093		3,093		4,028
Premium on fair value			$ 7,416
Future net profit						$ 15,809
Maturity date			Oct. 31, 2018
Accrued interest										436		2,055
Account payable								15,809		15,809		15,809
Greenhaus Analytical Services, LLC [Member]
Due to related parties						$ 340,000
Interest rate						6.00%
Current Portion - Notes Payable - Related Party						$ 340,000
Unamortized Debt discount								35,158		35,158		42,044
Debt discount						$ 55,277
Maturity date						Oct. 16, 2020
Accrued interest										29,678		19,506
Henry Grimmett [Member]
Quarterly payments						$ 25,000
Company repaid										2,000		25,100
Due to related parties						$ 194,512		117,412		117,412		169,412
Interest rate						0.00%
Short-term loan								50,000		50,000
Long-term note								$ 67,412		$ 67,412
Common stock shares issue								125,000		125,000
Common Stock, value								$ 62,500		$ 62,500
Extinguishment of debt amount										50,000
Losses on extinguishment of debt										15,000
Anthony Smith [Member]
Acquisition of business, amount				$ 636,000
Percentage owned				80.00%
Company repaid										25,000		50,000
Due to related parties								$ 236,000		$ 236,000		261,000
Interest rate								5.00%		5.00%
Series C Convertible Preferred Stock, Shares Issued				300,000
Preferred Stock value				$ 135,000
Short-term loan				$ 336,000
Accrued interest										$ 25,044		18,846
Sara Lausmann [Member]
Borrowed amount							$ 972,500
Due to related parties								$ 630,870		$ 630,870		689,870
Interest rate								5.00%		5.00%
Current Portion - Notes Payable - Related Party								$ 74,370		$ 74,370		89,870
Repayment to related party										59,000		82,630
Notes Payable - Related Party, less Current Portion								556,500		556,500		600,000
Series C Convertible Preferred Stock, Shares Issued							200,000
Preferred Stock value							$ 80,000
Short-term loan							72,500
Long-term note							$ 700,000
Accrued interest										64,222		47,409
Eric Ezrine, CR Labs, President [Member]
Due to related parties								130		130		$ 130
Interest rate												0.00%
Payment of severance agreement												$ 44,500
Repayment to related party												13,139
Account payable								8,450		8,450		22,450
Chief Executive Officer [Member]
Proceeds from notes payable - related party												80,100
Due to related parties								4,450		4,450		4,450
Repayment to related party												75,650
Newport Commercials Advisors [Member]
Management consulting services expenses								2,000	$ 13,124	14,317	$ 27,672
Chief Operating Officer [Member]
Borrowed amount												106,000
Due to related parties								$ 24,204		24,204		84,205
Repayment to related party										$ 60,000		$ 21,795

STOCKHOLDERS_ EQUITY (Details N

STOCKHOLDERS’ EQUITY (Details Narrative) - USD ($)	6 Months Ended	12 Months Ended
	Mar. 31, 2018	Sep. 30, 2017	Sep. 30, 2016
Common stock, par value	$ 0.0001	$ 0.0001
Common stock, shares authorized	1,000,000,000	1,000,000,000
Common stock, shares issued	16,068,505	10,732,922
Common stock, shares outstanding	16,068,505	10,732,922
Common shares issued for cash proceeds, Amount	$ 508,000	$ 112,000
Common shares issued for cash proceeds, Shares	1,270,000	112,000
Common shares issued for equity incentive plan, Amount	$ 75,755	$ 211,071
Common shares issued for equity incentive plan, Shares	57,000	93,691
Common shares issued for services valued, Amount	$ 254,720	$ 537,515
Common shares issued for services valued, Shares	207,750	333,949
Conversion of Convertible note and accrued interest into common stock, Shares	74,412	53,304
Conversion of Convertible note and accrued interest into common stock, Amount	$ 27,270	$ 30,975
Debt conversion converted instrument shares issued	670,271
Debt conversion original amount	$ 414,907
Share issued due to reverse stock split impact		1,755
Reverse stock split		1:100
Settlement of common share in accounts payable, share	37,500	10,000
Settlement of accounts payable	$ 15,000	$ 11,400
Common stock shares issued upon settlement of non-convertible debt	324,000	40,935
Non-convertible debt extinguished	$ 122,157	$ 46,666
Common stock shares issued upon settlement, Shares		5,000
Common stock shares issued upon settlement, Amount		$ 7,651
Share based compensation expense	$ 166,647
Series D Preferred Stock [Member]
Convertible Preferred Stock, Par Value	$ 0.0001	$ 0.0001
Convertible Preferred Stock, Shares Authorized	1,000,000	1,000,000
Convertible Preferred Stock, Shares Issued	552,500	832,500
Convertible Preferred Stock, Shares Outstanding	552,500	832,500
Fully paid and non assessable shares of Common Stock		2.5
Issuance of Common Stock		500
Common shares issued for cash proceeds, Amount		$ 114,500	$ 48,000
Common shares issued for cash proceeds, Shares		114,500	48,000
Common shares issued for acquisition, Amount		$ 670,000
Common shares issued for acquisition, Shares		670,000
Convertible preferred stock, shares converted	280,000
Stock conversion converted instrument shares issued	700,000
Liquidation preference		$ 1
Voting right description		Each holder of outstanding shares of Series D Preferred Stock shall be entitled to the number of votes equal to two hundred fifty (250) Common Shares
Common stock shares issuable upon conversion, Minimum		50,000
Series C Preferred Stock [Member]
Convertible Preferred Stock, Par Value	$ 0.0001	$ 0.0001
Convertible Preferred Stock, Shares Authorized	500,000	500,000
Convertible Preferred Stock, Shares Issued	500,000	500,000
Convertible Preferred Stock, Shares Outstanding	500,000	500,000
Fully paid and non assessable shares of Common Stock		5
Issuance of Common Stock		100
Liquidation preference		$ 1
Voting right description	Each holder of outstanding shares of Series C Preferred Stock shall be entitled to the number of votes equal to five (5) Common Shares.
Series C Preferred Stock [Member] | Oregon Analytical Services [Member]
Convertible Preferred Stock, Shares Issued			200,000
Series C Preferred Stock [Member] | Smith Scientific Industries, Inc. [Member]
Convertible Preferred Stock, Shares Issued			300,000
Series B Preferred Stock [Member]
Convertible Preferred Stock, Par Value	$ 0.0001	$ 0.0001
Convertible Preferred Stock, Shares Authorized	5,000,000	5,000,000
Convertible Preferred Stock, Shares Issued	5,000,000	5,000,000
Convertible Preferred Stock, Shares Outstanding	5,000,000	5,000,000
Voting right description	Each holder of outstanding shares of Series B Preferred Stock shall be entitled to the number of votes equal to one Common Share.
Series A Preferred Stock [Member]
Convertible Preferred Stock, Par Value	$ 0.0001	$ 0.0001
Convertible Preferred Stock, Shares Authorized	1,850,000	1,850,000
Convertible Preferred Stock, Shares Issued	0	0
Convertible Preferred Stock, Shares Outstanding	0	0
Common stock, shares issued	500,000,000
Common stock, shares outstanding	500,000,000
Convertible preferred stock, terms of conversion	Conversion at the Option of the Holder. From 12 months from the date of issuance, each holder of shares of Series A Preferred Stock may, at any time and from time to time, convert (an “Optional Conversion”) each of its shares of Series A Preferred Stock into fully paid and nonassessable shares of Common Stock at a rate equal to 4.9% of the Common Stock
Convertible preferred stock, conversion rate	13.24
Conversion price description	For a period of 18 months after the Preferred is convertible, the conversion price of the Series A Preferred will be subject to adjustment to prevent dilution in the event that the Company issues additional shares at a purchase price less than the applicable conversion price
Convertible preferred stock, shares converted		1,840,000
Stock conversion converted instrument shares issued		438,753
Convertible Notes Payable [Member]
Debt conversion converted instrument shares issued	1,869,650	1,142,892
Debt conversion original amount	$ 703,215	$ 765,050
Related party [Member]
Common stock shares issued upon settlement of non-convertible debt	125,000
Non-convertible debt extinguished	$ 50,000

LOANS PAYABLE (Details)

LOANS PAYABLE (Details) - USD ($)	Mar. 31, 2018	Sep. 30, 2017
Loan Payable	$ 1,065,691	$ 1,691,039
Less: unamortized original issue discounts	(37,024)	(127,662)
Total loans payable	1,028,667	1,563,377
Less: current portion of loans payable	975,192	1,503,545
Long-term portion of loans payable	53,475	59,832
Loans Payable One [Member]
Loan Payable	65,691	71,039
Loans Payable Two [Member]
Loan Payable	500,000	500,000
Loans Payable Three [Member]
Loan Payable	500,000	1,000,000
Loans Payable Four [Member]
Loan Payable		$ 120,000

LOANS PAYABLE (Details Narrativ

LOANS PAYABLE (Details Narrative) - USD ($)	Sep. 06, 2017	Aug. 01, 2017	Aug. 31, 2017	Mar. 16, 2017	Mar. 31, 2018	Sep. 30, 2017
Loan payable	$ 1,000,000		$ 120,000
Debt discount			$ 20,000		$ (499,998)	$ (208,680)
Interest rate	8.00%		8.00%
Maturity date	Jul. 6, 2018		Mar. 3, 2018
Cash proceeds from loans payable			$ 100,000
Purchase and Sale of Future Receivables agreement [Member]
Interest rate				6.637%
Maturity date				Mar. 31, 2023
Purchase and Sale of Future Receivables agreement [Member]
Loan payable		$ 500,000
Interest rate		8.00%
Maturity date		Jul. 1, 2018
Loans Payable [Member]
Accrued interest					39,682	$ 12,625
Acquisition [Member] | C3 Labs [Member]
Notes payable					$ 100,000

CONVERTIBLE NOTES PAYABLE (Deta

CONVERTIBLE NOTES PAYABLE (Details) - USD ($)	6 Months Ended	12 Months Ended
	Mar. 31, 2018	Sep. 30, 2017	Aug. 31, 2017
Principal amount	$ 1,218,185	$ 1,421,400
Unamortized Debt Discount	(499,998)	(208,680)	$ 20,000
Carrying Value	718,187	1,212,720
Accrued Interest	$ 49,610	$ 30,681
Noteholder 1 [Member]
Issue Date	Jul. 14, 2017	Mar. 2, 2017
Due Date	Jul. 14, 2018	Mar. 2, 2018
Principal amount	$ 40,300	$ 125,000
Unamortized Debt Discount	(26,071)	(38,112)
Carrying Value	14,229	86,888
Accrued Interest	$ 6,297	$ 5,671
Noteholder 1 One [Member]
Issue Date	Aug. 14, 2017	Jul. 14, 2017
Due Date	Aug. 14, 2018	Jul. 14, 2018
Principal amount	$ 275,600	$ 275,600
Unamortized Debt Discount	(200,290)	(11,795)
Carrying Value	75,310	263,805
Accrued Interest	13,815	$ 4,712
Noteholder 1 Two [Member]
Issue Date		Aug. 14, 2017
Due Date		Aug. 14, 2018
Principal amount		$ 275,600
Unamortized Debt Discount		(13,068)
Carrying Value		262,532
Accrued Interest		$ 2,839
Noteholder 4 [Member]
Issue Date		Mar. 2, 2017
Due Date		Mar. 2, 2018
Principal amount		$ 69,000
Unamortized Debt Discount		(50,009)
Carrying Value		18,991
Accrued Interest		$ 7,187
Noteholder 4 One [Member]
Issue Date		Jun. 5, 2017
Due Date		Mar. 2, 2018
Principal amount	275,600	$ 125,000
Unamortized Debt Discount	(200,289)	(70,833)
Carrying Value	75,311	54,167
Accrued Interest	$ 13,815	$ 3,205
Noteholder 4 Two [Member]
Issue Date		Jul. 14, 2017
Due Date		Jul. 14, 2018
Principal amount		$ 275,600
Unamortized Debt Discount		(11,795)
Carrying Value		263,805
Accrued Interest		$ 4,470
Noteholder 4 Three [Member]
Issue Date		Aug. 14, 2017
Due Date		Aug. 14, 2018
Principal amount		$ 275,600
Unamortized Debt Discount		(13,068)
Carrying Value		262,532
Accrued Interest		$ 2,597
Noteholder 4 [Member]
Issue Date	Jul. 14, 2017
Due Date	Jul. 14, 2018
Principal amount	$ 126,685
Unamortized Debt Discount	(73,348)
Carrying Value	53,337
Accrued Interest	$ 15,683
Noteholder 4 One [Member]
Issue Date	Aug. 14, 2017
Due Date	Aug. 14, 2018
Noteholder 5 [Member]
Issue Date	Jan. 1, 2018
Due Date	Jun. 30, 2018
Principal amount	$ 500,000
Unamortized Debt Discount
Carrying Value	500,000
Accrued Interest

CONVERTIBLE NOTES PAYABLE (De45

CONVERTIBLE NOTES PAYABLE (Details Narrative) - USD ($)	Sep. 06, 2017	Aug. 31, 2017	Mar. 31, 2018	Sep. 30, 2017
Convertible promissory note principal amount			$ 1,218,185	$ 1,421,400
Maturity date of note	Jul. 6, 2018	Mar. 3, 2018
Debt conversion converted instrument shares issued			670,271
Noteholder 4 [Member]
Convertible promissory note principal amount			$ 126,685
Noteholder 1 [Member]
Convertible promissory note principal amount			40,300	$ 125,000
March 2, 2017 [Member] | Transaction [Member] | Noteholder 4 [Member]
Debt conversion converted instrument shares issued				111,538
Debt conversion amount converted				$ 56,000
March 2, 2017 [Member] | Transaction [Member] | Noteholder 1 [Member]
Convertible promissory note principal amount			$ 125,000
Annual interest rate			8.00%
Accrued interest on note			$ 0	7,397
Convertible principal balance			0	125,000
August 14, 2017 [Member] | Transaction 2 [Member] | Noteholder 1 [Member]
Accrued interest on note				2,839
July 14, 2017 [Member] | Transaction 1 [Member] | Noteholder 1 [Member]
Cash proceeds from convertible promissory note			$ 250,000
Maturity date of note			Jul. 14, 2018
Debt conversion converted instrument shares issued			593,345
Description of conversion of note payable			The Note is convertible into the Company's common stock commencing 180 days from the date of issuance at a conversion price equal to 75% of the lowest trade price of the Company's common stock for the fifteen prior trading days including the date of conversion.
Converted shares during accrued interest			23,669
Noteholder 4 [Member] | March 2, 2017 [Member] | Transaction [Member]
Accrued interest on note				7,187
Convertible principal balance				69,000
Noteholder 4 [Member] | August 14, 2017 [Member] | Transaction 3 [Member]
Convertible promissory note principal amount			$ 275,600
Discount on convertible promissory note			15,600
Cash proceeds from convertible promissory note			$ 250,000
Annual interest rate			8.00%
Maturity date of note			Aug. 14, 2018
Accrued interest on note			$ 13,815	2,896
Convertible principal balance			$ 275,600
Description of conversion of note payable			The Note is convertible into the Company's common stock commencing 180 days from the date of issuance at a conversion price equal to 75% of the lowest trade price of the Company's common stock for the fifteen prior trading days including the date of conversion.
Amount paid to third party			$ 10,000
Noteholder 4 [Member] | July 14, 2017 [Member] | Transaction 2 [Member]
Convertible promissory note principal amount			275,600
Discount on convertible promissory note			15,600
Cash proceeds from convertible promissory note			$ 250,000
Annual interest rate			8.00%
Maturity date of note			Jul. 14, 2018
Accrued interest on note			$ 15,683	4,712
Convertible principal balance			$ 126,685
Debt conversion converted instrument shares issued			375,512
Convertible outstanding principal balance			$ 148,915
Description of conversion of note payable			The Note is convertible into the Company's common stock commencing 180 days from the date of issuance at a conversion price equal to 75% of the lowest trade price of the Company's common stock for the fifteen prior trading days including the date of conversion.
Amount paid to third party			$ 10,000
Noteholder 4 [Member] | March 2, 2017 [Member] | Transaction [Member]
Convertible promissory note principal amount			125,000
Cash proceeds from convertible promissory note			$ 125,000
Annual interest rate			8.00%
Maturity date of note			Mar. 2, 2018
Accrued interest on note			$ 0
Convertible principal balance			$ 0
Debt conversion converted instrument shares issued			219,258
Description of conversion of note payable			The Note is convertible into the Company's common stock commencing 180 days from the date of issuance at a conversion price equal to 65% of the lowest trade price of the Company's common stock for the twenty prior trading days including the date of conversion.
Debt conversion amount converted			$ 69,000
Noteholder 4 [Member] | March 2, 2017 [Member] | Transaction 1 [Member]
Convertible promissory note principal amount			125,000
Cash proceeds from convertible promissory note			$ 125,000
Annual interest rate			8.00%
Maturity date of note			Mar. 2, 2018
Accrued interest on note			$ 0
Convertible principal balance			$ 0
Debt conversion converted instrument shares issued			355,973
Description of conversion of note payable			The Note is convertible into the Company's common stock upon funding at a conversion price equal to 65% of the lowest trade price of the Company's common stock for the fifteen prior trading days including the date of conversion.
Debt conversion amount converted			$ 125,000
Noteholder 1 [Member] | Transaction 1 [Member]
Accrued interest due				4,712
Noteholder 1 [Member] | March 2, 2017 [Member] | Transaction [Member]
Cash proceeds from convertible promissory note			$ 125,000
Maturity date of note			Mar. 2, 2018
Debt conversion converted instrument shares issued			325,562
Description of conversion of note payable			The Note is convertible into the Company's common stock commencing 180 days from the date of issuance at a conversion price equal to 65% of the lowest trade price of the Company's common stock for the twenty prior trading days including the date of conversion.
Debt conversion amount converted			$ 125,000
Noteholder 1 [Member] | August 14, 2017 [Member] | Transaction 2 [Member]
Convertible promissory note principal amount			275,600
Discount on convertible promissory note			15,600
Cash proceeds from convertible promissory note			$ 250,000
Annual interest rate			8.00%
Maturity date of note			Aug. 14, 2018
Accrued interest on note			$ 13,815
Convertible principal balance			$ 275,600
Description of conversion of note payable			The Note is convertible into the Company's common stock commencing 180 days from the date of issuance at a conversion price equal to 75% of the lowest trade price of the Company's common stock for the fifteen prior trading days including the date of conversion.
Amount paid to third party			$ 10,000
Noteholder 1 [Member] | July 14, 2017 [Member] | Transaction 1 [Member]
Convertible promissory note principal amount			275,600
Discount on convertible promissory note			$ 15,600
Annual interest rate			8.00%
Accrued interest on note			$ 9,386
Convertible principal balance			40,300
Convertible outstanding principal balance			235,300
Amount paid to third party			10,000
Accrued interest due			$ 6,297
Noteholder 4 Four [Member] | March 2, 2017 [Member] | Transaction 1 [Member]
Accrued interest on note				3,205
Convertible principal balance				125,000
Noteholder 5 [Member] | On January 1, 2018 [Member]
Maturity date of note			Jun. 30, 2018
Convertible principal balance			$ 500,000	$ 0
Total convertible note payable			$ 500,000
Average trading price per share			$ 0.75
Description of trading price			In the event the average trading price of the Company’s common stock during the five days prior to maturity is less than $0.75 per share, the Company will pay the noteholder the difference between $0.75 and the average trading price during the preceding five days per share converted in cash.
Noteholder 5 [Member] | On January 1, 2018 [Member] | C3 Labs, LLC [Member]
Convertible exchange interest rate			60.00%

CONVERTIBLE DEBENTURES (Details

CONVERTIBLE DEBENTURES (Details)	6 Months Ended	12 Months Ended
	Mar. 31, 2018	Sep. 30, 2017
Expected term of options granted		5 years
Expected volatility		2.68%
Risk-free interest rate		1.89%
Expected dividend yield	0.00%	0.00%
Debt Issuance Costs [Member]
Expected term of options granted	2 years
Expected volatility	223.00%
Risk-free interest rate	2.49%
Expected dividend yield	0.00%

CONVERTIBLE DEBENTURES (Detai47

CONVERTIBLE DEBENTURES (Details 1)	6 Months Ended	12 Months Ended
	Mar. 31, 2018	Sep. 30, 2017
Expected term of options granted		5 years
Expected volatility		2.68%
Risk-free interest rate		1.89%
Expected dividend yield	0.00%	0.00%
Minimum [Member]
Expected term of options granted	4 years 11 months 22 days
Expected volatility	251.00%
Risk-free interest rate	2.01%
Maximum [Member]
Expected term of options granted	5 years
Expected volatility	256.00%
Risk-free interest rate	2.25%
Convertible debt [Member]
Expected term of options granted	2 years
Expected dividend yield	0.00%
Convertible debt [Member] | Minimum [Member]
Expected volatility	211.00%
Risk-free interest rate	2.09%
Convertible debt [Member] | Maximum [Member]
Expected volatility	223.00%
Risk-free interest rate	2.25%

CONVERTIBLE DEBENTURES (Detai48

CONVERTIBLE DEBENTURES (Details Narrative) - USD ($)	1 Months Ended	6 Months Ended
	Jan. 29, 2018	Mar. 31, 2018	Mar. 31, 2017	Sep. 30, 2017
Proceeds from issuance of convertible debt		$ 6,136,120
Common Stock, per share		$ 0.0001		$ 0.0001
Common Stock, valued		$ 1,607		$ 1,073
Outstanding principal		$ 6,583,000
Total number of convertible shares		670,271
Convertible debentures payable, net of discounts		$ 353,889
Unamortized debt discount		6,229,111		$ 0
Principal and accrued interest		$ 86,454
Unsecured Convertible Debentures [Member]
Number of units issued	5,973
Interest rate	8.00%
Principal face value	$ 1,000
Number of warrants	250
Proceeds from issuance of unsecured convertible debt	$ 5,973,000
Warrant exercise price	$ 0.80
Warrant period	24 months
Maturity date, description	The convertible debentures have a maturity date of 36 months from issuance.
Simple interest rate	8.00%
Convertible, conversion price per share	$ 0.60
Separate Debenture [Member]
Convertible, conversion price per share		$ 0.60
Warrants issued		152,500
Proceeds from issuance of convertible debt		$ 610,000
Common Stock, per share		$ 0.80
Convertible Debenture [Member]
Interest rate		6.00%
Warrant exercise price		$ 0.60
Warrant period		2 years
Warrants issued		597,300
Common Stock, per share		$ 0.60
Convertible debt, issuance cost		$ 702,963
Common Stock, valued		1,414,907
Proceeds from purchase of common stock		1,265,385
Debt issuance costs		3,383,255
Detachable warrants issued, valued		3,351,160
Outstanding principal		$ 6,583,000
Total number of convertible shares		10,971,667
Convertible Debenture One [Member]
Warrants issued		4,616,545
Debt issuance costs		$ 6,583,000
Debt discount		$ 4,465,131

DERIVATIVE LIABILITY (Details)

DERIVATIVE LIABILITY (Details) - Derivative Liability [Member] - USD ($)	6 Months Ended	12 Months Ended
	Mar. 31, 2018	Sep. 30, 2017
Beginning Balance	$ 294,637	$ 775,246
Initial measurement of derivative liabilities	6,115,697	1,312,384
Change in fair market value	(2,404,657)	(195,907)
Write off due to conversion	(882,454)	(1,597,086)
Ending Balance	$ 3,123,223	$ 294,637

DERIVATIVE LIABILITY (Details 1

DERIVATIVE LIABILITY (Details 1) - USD ($)	3 Months Ended		6 Months Ended
	Mar. 31, 2018	Mar. 31, 2017	Mar. 31, 2018	Mar. 31, 2017
Total derivative expense (gain)	$ 1,780,769	$ (85,035)	$ 1,794,091	$ (191,278)
Derivative Liability [Member]
Day one loss due to derivatives on convertible debt	(610,566)	(64,492)	(610,566)	(352,206)
Change in fair value of derivatives	2,391,335	(20,543)	2,404,657	160,928
Total derivative expense (gain)	$ 1,780,769	$ (85,035)	$ 1,794,091	$ (191,278)

DERIVATIVE LIABILITY (Details N

DERIVATIVE LIABILITY (Details Narrative) - USD ($)	3 Months Ended		6 Months Ended
	Mar. 31, 2018	Mar. 31, 2017	Mar. 31, 2018	Mar. 31, 2017	Sep. 30, 2017
Gain (loss) on change in fair market value of derivative liabilities	$ (1,780,769)	$ 85,035	$ (1,794,091)	$ 191,278
Debt discount from derivative liability				351,600
Reclassification of derivative liability to additional paid in capital			882,454	$ 889,509
Convertible promissory note principal amount	1,218,185		1,218,185		$ 1,421,400
Convertible Debentures [Member]
Gain (loss) on change in fair market value of derivative liabilities			2,413,650
Convertible debt	$ 6,583,000		$ 6,583,000
Maturity date, description			January 29, 2021 to March 8, 2021
Warrant issued to purchase of common stock	2,243,050		2,243,050
Aggregate fair value	$ 4,616,545		$ 4,616,545
Debt discount	4,465,131		4,465,131
Change in fair value of derivatives			$ 2,202,895
Risk-free interest rate			1.83%
Convertible Debentures [Member] | Minimum [Member]
Expected volatility rate			194.00%
Warrant exercise price			$ 0.60
Expected life			1 year 10 months 3 days
Convertible Debentures [Member] | Maximum [Member]
Expected volatility rate			205.00%
Warrant exercise price			$ 0.80
Expected life			1 year 10 months 17 days
Convertible Notes Payable Seven [Member]
Gain (loss) on change in fair market value of derivative liabilities			$ 299,373
Convertible promissory notes	275,600		$ 275,600
Maturity date			Aug. 14, 2018
Interest rate			8.00%
Conversion rate, description			conversion rate equal to a 25% discount from the lowest trading price in the fifteen trading days prior to conversion.
Aggregate fair value	329,356		$ 329,356
Debt discount	260,000		260,000
Fair value at initial measurement of derivative liability	69,356		69,356
Change in fair value of derivatives			$ 29,983
Expected volatility rate			128.00%
Risk-free interest rate			1.83%
Expected life			4 months 13 days
Convertible Notes Payable Six [Member]
Gain (loss) on change in fair market value of derivative liabilities			$ 248,420
Convertible promissory notes	275,600		$ 275,600
Maturity date			Aug. 14, 2018
Interest rate			8.00%
Conversion rate, description			conversion rate equal to a 25% discount from the lowest trading price in the fifteen trading days prior to conversion.
Aggregate fair value	330,278		$ 330,278
Debt discount	260,000		260,000
Fair value at initial measurement of derivative liability	70,278		70,278
Change in fair value of derivatives			$ 81,858
Expected volatility rate			128.00%
Risk-free interest rate			1.83%
Expected life			4 months 13 days
Convertible Notes Payable Five [Member]
Gain (loss) on change in fair market value of derivative liabilities			$ 38,442
Convertible promissory notes	275,600		$ 275,600
Maturity date			Jul. 14, 2018
Interest rate			8.00%
Conversion rate, description			conversion rate equal to a 25% discount from the lowest trading price in the fifteen trading days prior to conversion.
Aggregate fair value	419,796		$ 419,796
Debt discount	260,000		260,000
Fair value at initial measurement of derivative liability	159,796		159,796
Change in fair value of derivatives			7,253
Derivative liability due to conversion	374,101		$ 374,101
Expected volatility rate			128.00%
Risk-free interest rate			1.76%
Expected life			3 months 15 days
Convertible promissory note principal amount	235,300		$ 235,300
Convertible Notes Payable Four [Member]
Gain (loss) on change in fair market value of derivative liabilities			123,338
Convertible promissory notes	275,600		$ 275,600
Maturity date			Jul. 14, 2018
Interest rate			8.00%
Conversion rate, description			conversion rate equal to a 25% discount from the lowest trading price in the fifteen trading days prior to conversion.
Aggregate fair value	419,722		$ 419,722
Debt discount	260,000		260,000
Fair value at initial measurement of derivative liability	159,722		159,722
Change in fair value of derivatives			69,346
Derivative liability due to conversion	227,038		$ 227,038
Expected volatility rate			128.00%
Risk-free interest rate			1.76%
Expected life			3 months 15 days
Convertible promissory note principal amount	148,915		$ 148,915
Convertible Notes Payable Three [Member]
Gain (loss) on change in fair market value of derivative liabilities			0
Convertible promissory notes	125,000		$ 125,000
Maturity date			Mar. 2, 2018
Interest rate			8.00%
Conversion rate, description			conversion rate equal to a 35% discount from the lowest trading price in the fifteen trading days prior to conversion.
Aggregate fair value	157,523		$ 157,523
Debt discount	125,000		125,000
Fair value at initial measurement of derivative liability	32,523		32,523
Change in fair value of derivatives			5,967
Derivative liability due to conversion	106,332		$ 106,332
Expected volatility rate			113.00%
Risk-free interest rate			1.30%
Expected life			2 months 5 days
Convertible promissory note principal amount	125,000		$ 125,000
Convertible Notes Payable Two [Member]
Gain (loss) on change in fair market value of derivative liabilities			0
Convertible promissory notes	125,000		$ 125,000
Maturity date			Mar. 2, 2018
Interest rate			8.00%
Conversion rate, description			conversion rate equal to a 35% discount from the lowest trading price in the fifteen trading days prior to conversion.
Aggregate fair value	107,785		$ 107,785
Debt discount	107,785		107,785
Change in fair value of derivatives			4,043
Derivative liability due to conversion	111,758		$ 111,758
Expected volatility rate			111.00%
Risk-free interest rate			1.30%
Expected life			2 months 30 days
Convertible promissory note principal amount	125,000		$ 125,000
Convertible Notes Payable One [Member]
Gain (loss) on change in fair market value of derivative liabilities			0
Convertible promissory notes	125,000		$ 125,000
Maturity date			Mar. 2, 2018
Interest rate			8.00%
Conversion rate, description			conversion rate equal to a 35% discount from the lowest trading price in the fifteen trading days prior to conversion.
Aggregate fair value	107,768		$ 107,768
Debt discount	107,768		107,768
Change in fair value of derivatives			3,312
Derivative liability due to conversion	63,225		$ 63,225
Expected volatility rate			110.00%
Risk-free interest rate			1.30%
Expected life			3 months 4 days
Convertible promissory note principal amount	69,000		$ 69,000		56,000
Convertible Notes Payable [Member]
Derivative liability	3,123,223		3,123,223		$ 294,637
Gain (loss) on change in fair market value of derivative liabilities	$ 1,780,769		$ 1,794,091

ACQUISITIONS (Details)

ACQUISITIONS (Details) - USD ($)	Mar. 31, 2018	Sep. 30, 2017
ASSETS ACQUIRED
Other current assets	$ 63,546	$ 7,438
Goodwill	3,249,834	$ 2,958,137
C3 Labs, LLC [Member]
ASSETS ACQUIRED
Cash	20,468
Accounts receivable	5,110
Other current assets	3,461
Security deposits	20,000
Equipment	244,875
License	247,000
Customer list	112,000
Non-compete agreement	88,000
Goodwill	291,697
TOTAL ASSETS ACQUIRED	1,032,611
Accounts payable	4,314
Deferred rent	28,297
TOTAL LIABILITIES ASSUMED	32,611
Non-controlling interest	(400,000)
NET ASSETS ACQUIRED	$ 600,000

ACQUISITIONS (Details Narrative

ACQUISITIONS (Details Narrative) - USD ($)	3 Months Ended		6 Months Ended
	Mar. 31, 2018	Mar. 31, 2017	Mar. 31, 2018	Mar. 31, 2017
Proceeds from convertible notes payble			$ 6,136,120
Non-compete agreement period			5 years
Total revenues	$ 732,311	$ 832,723	$ 1,679,176	$ 1,501,179
License [Member]
Amortization period			7 years
Customer Lists [Member]
Amortization period			7 years
C3 Labs, LLC [Member] | January 1, 2018 [Member] | Convertible Notes Payable [Member]
Ownership percentage	60.00%		60.00%
Convertible notes payble, issued	$ 500,000		$ 500,000
Maturity date			Jun. 30, 2018
Convertible, conversion price per share	$ 0.75		$ 0.75
Notes payble, issued	$ 100,000		$ 100,000
C3 Labs, LLC [Member] | January 1, 2018 [Member] | Notes payble [Member]
Maturity date			Mar. 31, 2018
C3 Labs, LLC [Member] | January 1, 2018 to March 31, 2018 [Member]
Total revenues			$ 34,555
Purchase Agreement [Member]
Ownership percentage	60.00%		60.00%
Promissory notes, issued	$ 100,000		$ 100,000
Convertible promissory notes, issued	$ 500,000		500,000
Proceeds from convertible notes payble			$ 600,000
Option One [Member] | C3 Labs, LLC [Member] | January 1, 2018 [Member]
Option to purchase of additional interest, description			a) 30% Option. Effective as of Closing and terminating the date three (3) years from the Closing Date, the C3 Members hereby collectively grant EVIO the right to ratably purchase from the C3 Members an aggregate of 30% of the Interests in C3 LABS following the issuance of 60% of the Interests to EVIO. EVIO may exercise its option by providing C3 LABS and the C3 Members written notice of its intent to exercise the option. The C3 Members shall have three (3) days following the date of such notice to execute assignments of Interests totaling 30% of the then outstanding membership interests in C3 LABS in favor of EVIO California. If EVIO should elect to exercise its option within nine (9) months from the Closing Date, the exercise price for the 30% of Interests shall be $450,000.00, to be paid in cash or EVIO’s common stock, as agreed by the C3 Members. If EVIO does not exercise the option within nine (9) months from the Closing Date, the exercise price shall be set by mutual agreement between the parties or, if no such agreement can be reached, as determined by an independent third-party valuation by an appraiser agreed to by the parties.
Option Two [Member] | C3 Labs, LLC [Member] | January 1, 2018 [Member]
Option to purchase of additional interest, description			(b) 10% Option. Effective as of three (3) years after the Closing Date and terminating the date twenty four (24) months therefrom, the C3 Members hereby collectively grant EVIO the right to ratably purchase from the C3 Members an aggregate of 10% of the then outstanding Interests in C3 LABS (comprising the remaining Interests not owned by EVIO). EVIO may exercise its option by providing C3 LABS and the C3 Members written notice of its intent to exercise the option. The C3 Members shall have three (3) days following the date of such notice to execute assignments of Interests totaling 10% of the then outstanding membership interests in C3 LABS in favor of EVIO. Upon notice of its intent to exercise the option granted hereby, the exercise price shall be set by mutual agreement between the parties or, if no such agreement can be reached, as determined by an independent third-party valuation by an appraiser agreed to by the parties.

INDUSTRY SEGMENTS (Details)

INDUSTRY SEGMENTS (Details) - USD ($)	3 Months Ended		6 Months Ended		12 Months Ended
	Mar. 31, 2018	Mar. 31, 2017	Mar. 31, 2018	Mar. 31, 2017	Sep. 30, 2017
Revenue	$ 732,311	$ 832,723	$ 1,679,176	$ 1,501,179
Total assets					$ (200,000)
Depreciation and amortization	23,619	6,029	33,064	8,134
Corporate [Member]
Revenue
Segment income (loss) from operations	(1,264,646)	(163,362)	(1,459,932)	(378,704)
Total assets	4,262,523	93,328	4,262,523	93,328
Capital expenditures
Depreciation and amortization
Consulting Services [Member]
Revenue	43,300	87,297	102,816	187,175
Segment income (loss) from operations	(618,691)	(7,717)	(975,276)	4,648
Total assets	217,092	90,600	217,092	90,600
Capital expenditures			(1,038)	(1,038)
Depreciation and amortization	1,197	5,973	7,171	11,947
Testing Services [Member]
Revenue	689,011	745,426	1,576,360	1,314,004
Segment income (loss) from operations	(479,603)	(110,779)	(594,792)	(299,118)
Total assets	6,828,299	3,811,833	6,828,299	3,811,833
Capital expenditures	(524,562)	(19,450)	(530,476)	(44,726)
Depreciation and amortization	138,278	61,920	218,804	108,783
Total Consolidated [Member]
Revenue	732,311	832,723	1,679,176	1,501,179
Segment income (loss) from operations	(2,362,940)	(281,858)	(3,030,000)	(673,174)
Total assets	11,307,914	3,995,761	11,307,914	3,995,761
Capital expenditures	(524,562)	(19,450)	(531,514)	(45,764)
Depreciation and amortization	$ 139,475	$ 67,893	$ 225,975	$ 120,730

STOCK OPTIONS AND WARRANTS (Det

STOCK OPTIONS AND WARRANTS (Details) - $ / shares	6 Months Ended	12 Months Ended
	Mar. 31, 2018	Sep. 30, 2017
Number of Options
Number of options outstanding, beginning	655,000	315,000
Number of Options, Granted	3,948,050	380,000
Number of Options, Exercised
Number of Options, Forfeited	(70,000)	(40,000)
Number of Options, Expired
Number of options outstanding, ending	4,533,050	655,000
Weighted Average Exercise Price
Weighted average exercise price outstanding, beginning	$ 0.902	$ 0.449
Weighted Average Exercise Price, Granted	0.763	1.295
Weighted Average Exercise Price, Exercised
Weighted Average Exercise Price, Forfeited	0.891	1.075
Weighted Average Exercise Price, Expired
Weighted average exercise price outstanding, ending	$ 0.781	$ 0.902

STOCK OPTIONS AND WARRANTS (D56

STOCK OPTIONS AND WARRANTS (Details 1) - $ / shares	6 Months Ended	12 Months Ended
	Mar. 31, 2018	Sep. 30, 2017	Sep. 30, 2016
Outstanding Number of Option Shares	4,533,050	655,000	315,000
Outstanding Weighted Average Exercise Price	$ 0.781	$ 0.902	$ 0.449
Weighted Average Remaining Life (Years)	3 years 9 months 25 days	4 years 3 months 29 days
Exercisable Number of Option Shares	3,309,300	155,000
Exercisable Weighted Average Exercise Price	$ 0.754	$ 0.465
0.400 [Member]
Outstanding Number of Option Shares	120,000	150,000
Outstanding Weighted Average Exercise Price	$ 0.400	$ 0.400
Weighted Average Remaining Life (Years)	3 years 4 months 17 days	3 years 10 months 17 days
Exercisable Number of Option Shares	90,000	75,000
Exercisable Weighted Average Exercise Price	$ 0.400	$ 0.400
0.500 [Member]
Outstanding Number of Option Shares	165,000	155,000
Outstanding Weighted Average Exercise Price	$ 0.500	$ 0.500
Weighted Average Remaining Life (Years)	3 years 5 months 12 days	3 years 10 months 17 days
Exercisable Number of Option Shares	121,250	77,500
Exercisable Weighted Average Exercise Price	$ 0.500	$ 0.500
1.260 [Member]
Outstanding Number of Option Shares	230,000	270,000
Outstanding Weighted Average Exercise Price	$ 1.260	$ 1.260
Weighted Average Remaining Life (Years)	4 years 3 months	4 years 9 months
Exercisable Number of Option Shares	57,500
Exercisable Weighted Average Exercise Price	$ 1.260	$ 1.260
1.386 [Member]
Outstanding Number of Option Shares	60,000	60,000
Outstanding Weighted Average Exercise Price	$ 1.386	$ 1.386
Weighted Average Remaining Life (Years)	4 years 3 months	4 years 9 months
Exercisable Number of Option Shares	15,000
Exercisable Weighted Average Exercise Price	$ 1.386	$ 1.386
1.300 [Member]
Outstanding Number of Option Shares	10,000	10,000
Outstanding Weighted Average Exercise Price	$ 1.300	$ 1.300
Weighted Average Remaining Life (Years)	3 years 6 months 22 days	4 years 18 days
Exercisable Number of Option Shares	5,000	2,500
Exercisable Weighted Average Exercise Price	$ 1.300	$ 1.300
1.666 [Member]
Outstanding Number of Option Shares	10,000	10,000
Outstanding Weighted Average Exercise Price	$ 1.666	$ 1.666
Weighted Average Remaining Life (Years)	4 years 4 months 2 days	4 years 10 months 3 days
Exercisable Number of Option Shares	2,500
Exercisable Weighted Average Exercise Price	$ 1.666	$ 1.666

STOCK OPTIONS AND WARRANTS (D57

STOCK OPTIONS AND WARRANTS (Details 2)	6 Months Ended	12 Months Ended
	Mar. 31, 2018	Sep. 30, 2017
Stock Options And Warrants Details 2
Expected term of options granted		5 years
Expected volatility		2.68%
Risk-free interest rate		1.89%
Expected dividend yield	0.00%	0.00%

STOCK OPTIONS AND WARRANTS (D58

STOCK OPTIONS AND WARRANTS (Details 3) - $ / shares	6 Months Ended	12 Months Ended
	Mar. 31, 2018	Sep. 30, 2017	Sep. 30, 2016
Outstanding Number of Option Shares	4,533,050	655,000	315,000
Outstanding Weighted Average Exercise Price	$ 0.781	$ 0.902	$ 0.449
Weighted Average Remaining Life (Years)	3 years 9 months 25 days	4 years 3 months 29 days
Exercisable Number of Option Shares	3,309,300	155,000
Exercisable Weighted Average Exercise Price	$ 0.754	$ 0.465
0.400 [Member]
Outstanding Number of Option Shares	120,000	150,000
Outstanding Weighted Average Exercise Price	$ 0.400	$ 0.400
Weighted Average Remaining Life (Years)	3 years 4 months 17 days	3 years 10 months 17 days
Exercisable Number of Option Shares	90,000	75,000
Exercisable Weighted Average Exercise Price	$ 0.400	$ 0.400
0.500 [Member]
Outstanding Number of Option Shares	165,000	155,000
Outstanding Weighted Average Exercise Price	$ 0.500	$ 0.500
Weighted Average Remaining Life (Years)	3 years 5 months 12 days	3 years 10 months 17 days
Exercisable Number of Option Shares	121,250	77,500
Exercisable Weighted Average Exercise Price	$ 0.500	$ 0.500
0.600 [Member]
Outstanding Number of Option Shares	597,300
Outstanding Weighted Average Exercise Price	$ 0.600
Weighted Average Remaining Life (Years)	1 year 9 months 29 days
Exercisable Number of Option Shares	597,300
Exercisable Weighted Average Exercise Price	$ 0.600
0.650 [Member]
Outstanding Number of Option Shares	145,000
Outstanding Weighted Average Exercise Price	$ 0.650
Weighted Average Remaining Life (Years)	4 years 6 months 25 days
Exercisable Number of Option Shares
Exercisable Weighted Average Exercise Price	$ 0.650
0.800 [Member]
Outstanding Number of Option Shares	3,195,750
Outstanding Weighted Average Exercise Price	$ 0.800
Weighted Average Remaining Life (Years)	3 years 2 months 26 days
Exercisable Number of Option Shares	2,420,750
Exercisable Weighted Average Exercise Price	$ 0.800
1.260 [Member]
Outstanding Number of Option Shares	230,000	270,000
Outstanding Weighted Average Exercise Price	$ 1.260	$ 1.260
Weighted Average Remaining Life (Years)	4 years 3 months	4 years 9 months
Exercisable Number of Option Shares	57,500
Exercisable Weighted Average Exercise Price	$ 1.260	$ 1.260
1.300 [Member]
Outstanding Number of Option Shares	10,000	10,000
Outstanding Weighted Average Exercise Price	$ 1.300	$ 1.300
Weighted Average Remaining Life (Years)	3 years 6 months 22 days	4 years 18 days
Exercisable Number of Option Shares	5,000	2,500
Exercisable Weighted Average Exercise Price	$ 1.300	$ 1.300
1.386 [Member]
Outstanding Number of Option Shares	60,000	60,000
Outstanding Weighted Average Exercise Price	$ 1.386	$ 1.386
Weighted Average Remaining Life (Years)	4 years 3 months	4 years 9 months
Exercisable Number of Option Shares	15,000
Exercisable Weighted Average Exercise Price	$ 1.386	$ 1.386
1.666 [Member]
Outstanding Number of Option Shares	10,000	10,000
Outstanding Weighted Average Exercise Price	$ 1.666	$ 1.666
Weighted Average Remaining Life (Years)	4 years 4 months 2 days	4 years 10 months 3 days
Exercisable Number of Option Shares	2,500
Exercisable Weighted Average Exercise Price	$ 1.666	$ 1.666

STOCK OPTIONS AND WARRANTS (D59

STOCK OPTIONS AND WARRANTS (Details 4)	6 Months Ended	12 Months Ended
	Mar. 31, 2018	Sep. 30, 2017
Expected term of options granted		5 years
Expected volatility		2.68%
Risk-free interest rate		1.89%
Expected dividend yield	0.00%	0.00%
Minimum [Member]
Expected term of options granted	4 years 11 months 22 days
Expected volatility	251.00%
Risk-free interest rate	2.01%
Maximum [Member]
Expected term of options granted	5 years
Expected volatility	256.00%
Risk-free interest rate	2.25%

STOCK OPTIONS AND WARRANTS (D60

STOCK OPTIONS AND WARRANTS (Details Narrative) - USD ($)	3 Months Ended		6 Months Ended
	Mar. 31, 2018	Mar. 31, 2017	Mar. 31, 2018	Mar. 31, 2017
Stock Options And Warrants Details Narrative
Stock option expense	$ 986,203	$ 21,749	$ 1,067,768	$ 42,165
Unrecognized stock based compensation expense			$ 1,014,765

COMMETTMENTS AND CONTINGECIES61

COMMETTMENTS AND CONTINGECIES (Details)	Mar. 31, 2018USD ($)
Year ending September 30,
2,018	$ 258,300
2,019	475,761
2,020	445,092
2,021	248,667
2,022	118,410
Total	$ 1,546,230

COMMETTMENTS AND CONTINGECIES62

COMMETTMENTS AND CONTINGECIES (Details Narrative)	12 Months Ended
	Sep. 30, 2017USD ($)
Commettments And Contingecies Details Narrative
Purchase of software licence	$ 200,000
Impairment loss	$ (200,000)

SUBSEQUENT EVENTS (Details Narr

SUBSEQUENT EVENTS (Details Narrative)	May 02, 2018USD ($)	Apr. 29, 2018USD ($)$ / shares	Apr. 16, 2018USD ($)$ / sharesshares	May 02, 2018CAD ($)shares	Mar. 31, 2018USD ($)shares	Sep. 30, 2017USD ($)shares
Convertible note payable					$ 718,187	$ 1,212,720
Common Stock, value					$ 1,607	$ 1,073
Common stock share issued | shares					16,068,505	10,732,922
Common Stock Issuances [Member] | Convertible Promissory Note [Member]
Convertible note payable		$ 500,000
Maturity date description		12 months
Conversion price | $ / shares		$ 1.25
Common Stock Issuances [Member] | Convertible Notes Payable One [Member]
Convertible note payable					$ 45,135
Common stock share issued | shares					66,133
Common Stock Issuances [Member] | Convertible Notes Payable [Member]
Convertible note payable					$ 677,885
Common stock share issued | shares					992,265
Consultants [Member] | Common Stock Issuances [Member]
Common Stock, value					$ 18,750
Common stock share issued | shares					15,000
Subsequent Event [Member] | Common Stock Issuances [Member]
Common Stock, value					$ 157,000
Common stock share issued | shares					125,000
Subsequent Event [Member] | EVIO Canada, Inc [Member] | Stock Purchase Agreements [Member]
Ownership percentage				50.00%
Interest rate	8.00%
Business acquisition equity method investment purchase price	$ 2,495,000
Business acquisition advances to given under agreement	$ 1,000,000
Subsequent Event [Member] | EVIO Canada, Inc [Member] | Private Placement [Member]
Common stock shares subscribed | shares				1,291,391
Common stock shares subscribed, value				$ 1,950,000
Subsequent Event [Member] | Chief Financial Officer [Member]
Exercise price | $ / shares			$ 1.28
Term of agreement			2 years
Basic salary			$ 150,000
Stock options granted | shares			150,000
Common stock shares granted | shares			200,000
Bonuses			$ 20,000